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Cell signaling is essential for all living systems to sense the environment, process information, 
and maintain homeostasis. Biological assemblies composed of enzymes, scaffold proteins, and 
chemical messengers organize signaling networks in both space and time in order to integrate 
and transduce diverse inputs. However, the mechanistic underpinnings of these processes in 
many pathways remain poorly characterized.  
Genetically encoded biosensors incorporating fluorescent proteins have revolutionized our study 
of signaling networks by illuminating the communication and regulatory processes between 
important pathway components in live cells (reviewed in Chapter 1). In this dissertation, 
biosensors were applied to study compartmentalized signaling within the Ca
2+
-cAMP-PKA 
oscillatory circuit in pancreatic beta cells (Chapter 2). Significantly, this work uncovered 
nanoscale spatial regulation of the circuit’s phase between oscillatory Ca
2+
 and cAMP/PKA and 
suggests that the phase, in addition to the frequency and amplitude, can be utilized as an 
additional scheme for informational encoding within a signaling circuit. Measuring such 
compartmentalized signals can be fraught with complications due to the artificial expression of 
biosensors fused to proteins-of-interest. In Chapter 3, a novel platform is introduced in which 
genetic knock-in of a tag can be used to recruit a suite of biosensors to an endogenous protein-of-
interest for compartmentalized signaling interrogation. These FluoSTEPs (Fluorescent Sensors 
Targeted to Endogenous Proteins) are employed to study differential cAMP signaling at a variety 
of important regulatory microdomains. Uncovering the dynamic interplay and coordination 
between several signaling components within individual cells with genetically encoded 
biosensors can be difficult due to finite spectral space. Thus, in Chapter 4, two families of 
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biosensors are introduced to address this limitation: 1) FLAREs (FLuorescence Anisotropy 
REporters) utilize changes in polarization during homo-FRET to produce single-color, 
ratiometric readouts of biochemical activities and 2) single-color biosensors based on a single 
fluorescent protein can report sensitive changes in signaling dynamics with a reduced spectral 
footprint. Design and optimization of such sensors benefited from high-throughput screening for 
favorable mutations, and so various screening platforms are also covered here. These genetically 
encoded biosensors add to the ever-growing repertoire of tools researchers can employ for 
dissecting signaling pathways in live cells.  
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Protein complexes play a major role in transducing information from outside the cell into 
instructions for growth and survival, and understanding how these complexes relay and shape 
intracellular signals has been a central question in signaling biology. Fluorescent proteins have 
proven paramount in opening windows for researchers to peer into the architecture and inner 
workings of signaling assemblies within the living cell and in real-time. In this review, we will 
provide readers with a current perspective on the development and use of genetically encoded 
optical probes to dissect the function of signaling complexes. 
 
Introduction 
Signaling networks are essential for cells to sense their environment and rapidly translate 
external information into decisions that promote growth and sustainability. Due to the 
complexity of the intracellular space, these networks have evolved multimolecular assemblies to 
facilitate signal transduction by specifically positioning enzymes and substrates for interaction 
[1]. Extensive biochemical characterization over the last few decades has provided researchers a 
glimpse into the assembly of signaling complexes and the mechanisms through which they shape 
signals. However, obtaining a more complete understanding of intracellular communication 
requires tools that are capable of capturing the spatiotemporal dynamics of these processes 
within individual living cells. 
 
Recent technological advances in live-cell imaging and the landmark discovery of fluorescent 
proteins (FPs) have revolutionized the signaling field and led to the development of genetically 
encoded biosensors for interrogating signaling in the native biological context as opposed to in 
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the test tube [2]. In addition, these tools have opened up the possibility of monitoring individual 
cells at the time scale at which signaling events occur, whereas bulk measurement techniques 
often fall short of accurately describing the cell-to-cell heterogeneity of signaling, i.e., an 
average response can mask important dynamics, such as oscillations and transient spiking [3]. 
Further adaptations of these tools over the last ten years have promoted the design of 
fluorescence-based biosensors that can actually provide mechanistic descriptions of signaling 
assemblies by measuring localized protein-protein interactions (PPIs), second messenger 
concentrations, and enzymatic activities [4].   
 
In this chapter, we will briefly cover some of the optical-based tools that are currently utilized to 
probe multiprotein signaling complexes. The technologies covered here are not exhaustive, but 




Signaling complexes can be assembled from many different enzymes, adaptors, and scaffolds, 
forming a localized, information-rich protein interaction network. The components within the 
assembly can exist in many physiologically relevant molecular states, such as being bound to the 
complex, being chemically modified, or adopting a specific conformation [1]. Perturbations to 
the composition of an assembly, for example, by mutations, often transform signaling pathways 
and can cause detrimental effects such as cancer and Alzheimer’s disease [5,6]. To understand 
the signal-shaping mechanisms of these multiprotein machines, it is important to characterize the 
dynamic PPIs in the local context of the living cell. Below, we outline a few technologies that 
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have assisted researchers in dissecting the architecture of signaling complexes and highlight 
current developments that push the limits of measurement. 
 
From revealing the composition of a signaling complex to measuring the dynamic changes 
within a signaling complex, Förster Resonance Energy Transfer (FRET) is a powerful tool for 
probing PPIs. FRET involves the non-radiative transfer of energy from an excited donor 
fluorophore to an acceptor fluorophore. This photophysical process is immediate and functions 
effectively in the 1-10 nm regime with an inverse (distance)
6
 dependence, making FRET a 
sensitive method to study interactions at the scale of macromolecules in situ (Figure 1a) [7]. 
Advancements in imaging/detection techniques and the discovery of spectral FP variants have 
led to the routine utilization of FRET in signaling research. 
 
Many signaling interactions occur quickly and reversibly, and thus require dynamic, reversible 
probes. Non-covalent interactions can be effectively coupled to the distance-dependent FRET 
signal by directly fusing or tagging the proteins of interest to fluorescent proteins [8]. This 
methodology has been utilized to build signaling network models. For example, the G-protein 
signaling pathway comprises many PPI events, including receptor activation, G-protein 
dissociation, and receptor recycling; almost every ligand-induced event in this pathway has been 
monitored using FRET [9,10]. In addition, many of the players undergo conformational changes 
upon binding or unbinding, and FRET can be used to the measure these changes in an 
intramolecular fashion. For example, ligand-inducible changes of GPCRs can be monitored by 
inserting CFP into an intracellular loop and placing YFP at the C-terminus [11]. The G-protein 
pathway has also benefitted from BRET, another resonance energy transfer-based method that 
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utilizes a bioluminescent luciferase as the energy donor, obviating the need for potentially 
damaging exogenous illumination and leading to less photobleaching and lower background 
[12]. 
 
The finite range of the visible spectrum and the broad excitation and emission spectra of FPs can 
make FRET a spectrally expensive technique [13]. Fortunately, alternative single-color methods 
can also be employed. The EGF receptor is known to dimerize and oligomerize upon stimulation, 
but only recently has a method for monitoring real-time changes in multimerization been 
reported [14]. This technique, known as homo-FRET, involves FRET between identical 
fluorophores and can be quantified by measuring the polarization of emitted light at a single 
wavelength relative to the excitation light [15,16]. Homo-FRET has been successfully applied to 
measure receptor clustering by labeling the EGF receptor with a single, monomeric GFP and 
measuring the loss of fluorescence anisotropy [17]. Live-cell imaging using this single-color 
technique led the authors to conclude that EGFR dimerization is the result of receptor activation 
instead of the converse [14].  
 
Signaling complexes typically contain several physiologically important PPIs that are also 
incredibly dynamic. To monitor multiple interactions within a complex simultaneously, 
researchers are extending hetero-FRET for use with multiple donors and acceptors. For example, 
T-cell activation and subsequent cytoskeletal rearrangement is initiated by a multiprotein 
assembly comprised of the GEF Vav1 and adaptor proteins Nck and SLP-76 [18]. 
Immunoblotting revealed the identities of the key components, but the specific PPIs and the 
dynamics governing complex formation remained elusive. Utilizing the distance dependence of 
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FRET to monitor extremely local interactions in real-time, Pauker et al. fused three spectrally 
distinct FPs to the three components [18]. In order to detect all interactions after T-cell 
activation, an imaging scheme was needed to subtract spectral bleed-through and account for 
indirect FRET through an intermediate acceptor/donor. This study demonstrated that Nck and 
Vav1 exist as a constitutive heterodimer and that activation triggers the binding of SLP-76 to 
Nck on the timescale of seconds. This powerful multi-color FRET imaging approach to monitor 
many interactions simultaneously has been proposed to work with N spectrally distinct FPs, 
provided the appropriate corrections and controls are applied [19,20]. 
 
Despite its sensitivity to small changes in distances, FRET can be limited by poor signal-to-noise 
ratios and the requirement that a large subset of FPs must associate to produce a detectable signal 
[21,22]. These restrictions tend to hamper the study of very weak/transient and/or rare 
interactions [23,24]. For example, the binding of effectors to tyrosine kinases via SH3 domains 
regulates many important cell processes; however, these interactions tend to be short-lived, 
making FRET a less-than-optimal detection method [23,24]. An alternative technique involves 
the creation of a fluorescent signal when two proteins are in close proximity. By splitting a 
fluorescent protein into two non-fluorescent fragments and fusing each to an SH3 domain and a 
binding effector, heterodimerization can be measured and imaged by the reconstitution of the FP 
and the gain of fluorescence (Figure 1b) [27,28,29]. Although the irreversibility of this process 
and the time required for fluorophore maturation (minutes to potentially hours) prevent detailed 
dynamic measurements, bimolecular fluorescence complementation (BiFC) is well-suited for 
visualizing weak interactions within the cell [29]. Multiple BiFC-capable FP variants are also 
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available and have been successfully utilized to image many PPIs, including homo- and hetero-
dimers of the adenosine and dopamine receptors simultaneously [30].  
 
Increasing evidence suggests that signaling assemblies are spatially organized at the nanometer 
scale; however, the spatial resolution of the above methods is limited by the diffraction of light 
(~250nm) [31,32,33]. In order to map PPIs at a resolution commensurate to their molecular 
scale, BiFC has been extended to incorporate photo-activatable FPs for super-resolution imaging. 
For example, the GTPase Ras has been shown to exist in functionally-important ‘nanoclusters,’ 
but the organization of Ras-binding effectors, such as Raf, is poorly understood [34]. Recently, a 
BiFC-compatible split version of photo-activatable mCherry was generated, and each end was 
fused to either Ras or Raf [35]. Both standard Photo-activated Localization Microscopy (PALM) 
imaging and single-particle tracking were used to map the clustered heterodimers and their 
collective motion. However, the inherent tradeoff between spatial and temporal resolution 
prohibited the extraction of meaningful dynamic information using BiFC-PALM. A recently 
reported super-resolution BiFC technique sought to strike a balance and permit live-cell 
detection of PPIs. Utilizing a split photoblinking Venus, the functionally-relevant association 
between the calcium store sensor Stim1 and the store-operated calcium channel Orai1 was 
mapped using reconstituted fluorescence-based stochastic optical fluctuation imaging (refSOFI) 
[36]. 
 
In certain applications, the only pertinent information for researchers is the inclusion or absence 
of specific effectors within an assembly. The high signal-to-noise ratio of BiFC thus permits 
cellular screening to probe assembly architecture [37]. For example, the important regulatory 
8 
 
kinase PKB/Akt functions in cell growth, proliferation, and apoptosis; however, not all of the 
bound effectors of PKB have been characterized [38]. In a first-of-its-kind experiment, a split-
GFP screen to identify novel effectors of PKB was performed by fusing one GFP fragment to a 
cDNA library of ‘prey’ proteins, and fusing the other fragment to PKB. By screening thousands 
of ‘prey’ proteins, researchers found one, Ft1, that binds to and promotes the association of PKB 
with PDK1 [39]. Due to the involvement of PPIs in many diseases, there has also been a large 
push to develop high-throughput assays for drug development. A recently described high-content 
screen to find inhibitors of the activity-dependent dimerization of an HIV-1 accessory factor 
using split YFP identified several hit compounds [40]. Improvements in BiFC for screening 
continue and include a tripartite fluorescence complementation assay to both study ternary 
complexes and reduce background complementation, as well as a split near-infrared FP to allow 





























Figure 1.1 Assembly architecture 
A signaling complex’s internal architecture can be probed by tagging components with 
fluorescent proteins (FPs). As schematically shown in (a), two interacting proteins, such as a 
GPCR and β-arrestin, are tagged with FPs capable of FRET. BiFC can also be utilized to detect 
PPIs, as shown in (b). Two nonfluorescent FP fragments are fused to an interacting protein pair, 








Assembly-based signaling functions 
Many signaling networks rely on the formation of signalosomes, kinetically-distinct 
nanodomains comprised of key signaling players and effectors, in order to ‘reshape,’ or modify, 
downstream dynamics and optimize specific enzymatic reactions [1]. In the previous section, we 
looked at methods to dissect the components and interactions within an assembly. In this section, 
we will focus on methods, primarily using biosensors, to study the mechanisms by which 
signalosomes regulate signaling pathways. 
 
Genetically encoded biosensors 
Genetically encoded biosensors have become a valuable tool in allowing researchers to measure 
the spatiotemporal dynamics of intracellular signals within living cells. Their strength lies in 
their ability to specifically monitor changes in biochemical activities in real-time and with 
minimal invasiveness to the cell [44,45]. Biosensors generally comprise two parts: a sensing 
component and a reporting component [46,47]. The sensing component is responsible for 
detecting the relevant biochemical change through either a binding/unbinding event or protein 
modification, leading to a conformational change. The reporting component translates the 
conformational change into a detectable signal, most often via fluorescence or bioluminescence. 
For example, the genetically encoded calcium sensor Cameleon utilizes a calcium-dependent 
conformational switch composed of calmodulin and a fragment of myosin light-chain kinase 
sandwiched between a CFP/YFP FRET pair (Figure 2a) [48]. This same sensing unit has also 
been used to generate a collection of high-contrast, single-color probes that have gained in 
popularity (Figure 2b) [49,50]. In addition, an entire suite of kinase activity biosensors have been 
engineered by fusing a kinase-specific substrate domain to a phosphoaminoacid binding domain 
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and flanking this switch between a FRET pair (Figure 2c) [51]. Phosphorylation of the substrate 












































Figure 1.2 Genetically encoded biosensors 
FP-based, genetically encoded biosensors are used to measure changes in signaling activities and 
concentrations. In (a), the FRET-based calcium reporter Cameleon works by binding calcium via 
a calmodulin domain (CaM) and triggering binding to a domain derived from myosin light chain 
kinase (M13). This conformational change then elicits FRET by bringing two fused FPs into 
proximity. As shown in (b), a suite a single-color calcium reporters, known as GCaMPs, have 
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been developed that utilize the same CaM and M13 domains but fused to different parts of a 
circularly-permuted GFP. Calcium binding modulates the GFP’s fluorophore, leading to 
increased fluorescent emission. Kinase activity can also be sensed using similar design principles 
as Cameleon, as seen in (c). The sensing unit is comprised of a kinase-specific substrate domain 
that, once phosphorylated, binds to a general phosphoaminoacid binding domain (PAABD), and 




Biosensors to study signalosome functions 
To directly probe localized signaling within a signalosome, biosensors are frequently fused to a 
component of the multiprotein complex. Many signaling networks include scaffold and/or 
adaptor proteins that organize PPIs within an assembly, and biosensors have helped uncover a set 
of design principles complexes utilize to modify signal behavior. For example, fusing a FRET-
based reporter for PKA activity (AKAR) to a class of A-kinase anchoring proteins (AKAPs) 
revealed accelerated activity kinetics (t1/2 ≈ 2s, representing approx.. two orders of magnitude 
difference)  and increased activity amplitude upon PKA stimulation, demonstrating that scaffolds 
can create kinetically distinct nanodomains (Figure 3) [52,53]. Furthermore, a recent AKAP-
fused biosensor study revealed that the activity of AKAP-bound protein kinase C (PKC) is not 
only accelerated and amplified but is also ‘insulated’ from competitive inhibitors, as compared 
with general PKC activity at the plasma membrane. AKAPs and other scaffold proteins have also 
been shown to interact with many additional signaling proteins, such as adenylyl cyclases, 
phosphodiesterases (PDEs), and phosphatases, and can increase the specificity of certain signals 
[53]. For example, deletion of the PDE-binding domain in a particular AKAP was shown to 
reshape the stimulated PKA activity from a transient response into a more sustained response 
[52]. Biosensors are indispensable tools in dissecting the mechanisms that complexes use to 
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modify intracellular signaling and precisely control the spatiotemporal dynamics of signaling 
cascades. 
 
Many groups are continuously pushing the boundaries of genetically encoded biosensor design. 
Due to their reliance on fluorescence or bioluminescence, the challenges facing biosensors are 
similar to the limitations of tools for probing assembly architecture, namely, limits of spectral 
space and signal intensity. As mentioned previously, a set of new near-IR FPs have been 
optimized and shown to be suitable as FRET acceptors for in vivo reporting [54,55]. Despite 
finite spectral space, other groups have pushed the limits of multiplexing by co-expressing many 
biosensors and using innovative multi-dimensional unmixing methods [56]. The use of single-
color biosensors frees much of the visible spectrum but often at the cost of losing a ratiometric 
measurement. However, a new class of biosensors utilizing homo-FRET permits a single-color, 
ratiometric readout by measuring changes in the steady-state fluorescence anisotropy [57]. 
Bottlenecks for biosensor development typically reside in the initial design and optimization 
stages of a new reporter; however, many groups have turned to higher-throughput screening 
procedures to rapidly test thousands of sensor/FP variants and evolve these mutants into better 
sensors. Lysate and bacterial colony screens, as well as microfluidic-based approaches, are 
becoming a mainstay in the development pipeline, resulting in probes with increased dynamic 











Figure 1.3 Macromolecular assemblies tune signaling 
Signaling complexes tend to fundamentally alter dynamics within a signalosome. Many 
important signaling enzymes, such as the cAMP dependent kinase PKA, are localized throughout 
the cell by interacting with scaffold proteins as well as with a variety of additional effectors. 
Genetically encoded biosensors can measure signaling dynamics both within these signalosomes 
and in the cytosol. In the case of PKA, it has been shown that stimulated PKA activity is both 
accelerated and amplified within a PKA anchoring protein (AKAP)-centric signalosome, as 






Conclusions and future perspectives 
Although far from exhaustive, this review highlights a few optical methods for probing signaling 
assemblies. From monitoring PPIs to interrogating the functional roles of multiprotein 
complexes, genetically encoded tools allow researchers to measure the spatiotemporal signatures 
of specific signaling networks in living cells and tissues.  
 
Despite the high sensitivity and specificity of biosensors, the ability to report biological changes 
is sometimes hampered by overexpression, and thus requires a number of control experiments. 
Stably expressing cell lines and/or endogenously-fused sensors could alleviate such concerns. 
Recent progress in employing CRISPR/Cas9 for gene knockin has spurred interest in the 
development of endogenously expressed sensors for PPIs and activity [60]. 
 
The boundaries for attaining higher-resolution maps of interactions and activities within the cell 
are constantly being pushed. As mentioned previously, new methods such as BiFC-PALM and 
refSOFI allow researchers to image PPIs below the diffraction limit. In addition, the 
heterogeneity in the composition and mechanistic function of multiprotein assemblies suggests 
the need to study complexes at the single-molecule level instead of adopting ensemble 
approaches. Newer techniques such as single-molecule pull-down (SiMPull) provide a platform 
for extracting individual protein complexes from cells and tissues for single-molecule 
investigation [61]. The advent of brighter organic fluorophores and protein-tagging systems such 
as SNAP and Halo could also offer the possibility to utilize single-molecule FRET to directly 
probe individual signaling complexes [62]. In addition to improvements in spatial resolution and 
single-molecule detection, progress in attaining higher temporal resolution for biosensors have 
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afforded researchers the ability to measure extremely rapid signals such as calcium spikes and 
action potentials with millisecond to submillisecond accuracy [63,64]. 
 
Fluorescence and bioluminescence-based tools for studying macromolecular complexes and 
signalosomes have contributed greatly to our understanding of intracellular signaling. Persistent 
innovation, including better fluorophores and robust tool design, will continue to allow 
researchers to design comprehensive and detailed experiments to probe the spatiotemporal 
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Signaling networks are spatiotemporally organized in order to sense diverse inputs, process 
information, and carry out specific tasks. In pancreatic beta cells, calcium, cyclic adenosine 
monophosphate (cAMP), and Protein Kinase A (PKA) exist in an oscillatory circuit 
characterized by a high degree of feedback, and this circuit is instrumental in mediating and 
potentiating pulsatile insulin secretion. Here we describe a novel mode of regulation within this 
circuit involving the spatial compartmentalization of the relative phase between cAMP, PKA, 
and calcium. We show that nanodomain clustering of calcium-dependent adenylyl cyclases 
drives oscillations of local cAMP levels within the membrane nanodomain to be precisely in 
phase with calcium oscillations, whereas a shifted balance towards calcium-dependent 
phosphodiesterases allows out of phase oscillations to occur within the general plasma 
membrane, providing a striking example and novel mechanism of cAMP compartmentation. 
Disruption of this precise in-phase relationship leads to irregular calcium oscillations, suggesting 
that the relative phase within an oscillatory circuit can encode specific functional information. 
This example of a signaling nanodomain utilized for localized tuning of an oscillatory circuit has 
broad implications for the spatiotemporal coordination of many biological networks.  
Introduction 
Cyclic adenosine monophosphate (cAMP) and Ca
2+
 act as essential second messengers in almost 
every cell type and regulate many functional pathways within a cell, such as hormonal signal 
transduction, metabolism, and secretion (Sassone-Corsi 2012; Clapham 2007). In some cell 
types, like neurons, cardiomyocytes, and pancreatic beta cells, these messengers’ concentrations 
oscillate intracellularly (Dupont et al. 2011; Dyachok et al. 2006.), and the oscillations encode 
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dynamic signaling information (eg. signal strength, duration, target diversity) into parameters 
such as frequency and amplitude (Berridge et al. 1998; De Pitta et al. 2008). In beta cells, Ca
2+
, 
cAMP, and the cAMP dependent kinase, Protein Kinase A (PKA), constitute a highly-
coordinated oscillatory circuit with key components instrumental in integrating different signals 
to regulate diverse functions including insulin secretion (Ni et al. 2011; Draznin 1988). Although 
much attention has been directed towards understanding the temporal control of key players 




 is transported from one location to another (eg. extracellular to intracellular, internal 
stores to cytoplasm, or vice versa), cAMP is synthesized from ATP by adenylyl cyclases (ACs) 
and degraded into AMP by phosphodiesterases (PDEs) throughout the cell (Hanoune et al. 2001; 
Bender et al. 2006). cAMP signaling, due to its potency, target diversity, and functional 
specificity, is spatiotemporally controlled by compartmentalization of ACs and PDEs via 
macromolecular interactions and organelle localization (Calebiro et al. 2014). In the beta cell, the 
plasma membrane (PM)-localized scaffold protein AKAP79 (AKAP150 rodent orthologue) 
associates with various regulators of cAMP, as well as with Ca
2+ 
channels, PKA, and secretory 
machinery, and global knock-out correlates with impaired Ca
2+
 influx, defective glucose-
stimulated insulin secretion (GSIS), and reduced cAMP fluctuations (Hinke et al. 2012). 
In this study, we investigated the spatiotemporal regulation of the Ca
2+
-cAMP-PKA oscillatory 
circuit within the signaling microdomain assembled by AKAP79/150 in MIN6 beta cells. We 
found that the relative, oscillatory phase between cAMP/PKA and Ca
2+
 is shifted in the 
immediate vicinity of the AKAP79/150 scaffold, compared to the general plasma membrane 
compartment. We also examined the nanoscale organization of key circuit regulators at the 
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plasma membrane and probed the spatial regulation and functional consequences of the phase 
relationship. 
Results 
The phase of oscillatory cAMP relative to Ca
2+
 is compartmentalized  
AKAP79/150 organizes a macromolecular complex with binding partners that include PKA, 
voltage-gated Ca
2+





-regulated ACs, AMPA receptors, and many others (Gold et al. 
2011). Due to the extensive, multivalent nature of AKAP79/150 and the functional impairment 
of GSIS in beta cells upon knock-out (Hinke et al. 2012), we hypothesized that the AKAP79/150 
scaffold might play a role in the spatiotemporal regulation of the Ca
2+
-cAMP-PKA oscillatory 
circuit. Specifically, we proposed that AKAP79/150 might be able to create a kinetically-distinct, 
regulatory nanodomain that is able to finely-tune and shape signaling within the circuit (Tenner 
2016) In order to test this hypothesis, we fused full-length AKAP79 to the FRET-based 
biosensor (Ci/Ce)Epac2-camps (Everett et al. 2013) to monitor cAMP dynamics in the 
immediate vicinity of AKAP79/150 (Figure 2.1a), and transiently transfected the targeted sensor 
and the red Ca
2+
 reporter RCaMP (Akerboom et al. 2013), in MIN6 beta cells. The cAMP sensor 
was clearly membrane-localized via palmitoylation and polybasic domains of AKAP79 (Delint-
Ramirez et al. 2011) (Figure 2.1a). Upon treatment with tetraethylammonium chloride (TEA, 
20mM), a potent K
+ 
channel blocker, to trigger the oscillatory circuit, we observed synchronized, 
oscillatory cAMP/Ca
2+
 responses. Despite the cell-to-cell heterogeneity of the oscillating Ca
2+
 
signal (ie. variations in frequency, amplitude, and regularity), significant subpopulations of cells 
displayed cAMP oscillations that were either in phase (approx. 36%) or completely out of phase 
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(approx. 32%) with their Ca
2+
 signal (approx. 32% were unresponsive/indeterminate) (Figure 
2.1b). Explicitly, each transient spike in intracellular Ca
2+
 was associated with either a transient 
increase in cAMP (“in-phase”) or a transient decrease in cAMP (“out-of-phase”), in responding 
cells. To quantify the cAMP-Ca
2+
 phase relationship, we measured the lag time by calculating 
the cross-correlation between the two normalized, oscillatory signals and finding the absolute 
value of the shortest delay yielding the maximum correlation (Figure 1d,e). In-phase cAMP 
oscillations corresponded to short lag times (typically < 20sec) while out-of-phase oscillations 
mostly possessed longer lag times. The observed in-phase cAMP oscillations within 
AKAP79/150 microdomains (avg. time lag 13sec ± 3sec, n=60) is striking (Figure 2.1b), 
especially compared to previous measurements of cytoplasmic cAMP using untargeted sensors 
that yielded only out-of-phase oscillations (Ni et al. 2011; Landa et al. 2005). Importantly, we 
also found that the lag time for AKAP79/150-centric cAMP correlated strongly with sensor 
expression with cells with low levels of sensor present displaying predominantly in-phase cAMP 
oscillations and cells with high levels of the AKAP79/150-fused biosensor exhibiting out-of-
phase oscillations. Overexpression of AKAP79/150 likely changed the stoichiometry of 
signaling complexes and resulted in unsuccessful targeting of the biosensor to functional 
AKAP79/150 microdomains, and so in all subsequent analysis except where noted (eg. “highly-
expressed” sensor) we considered only responding cells below an empirically-determined 
AKAP79-sensor expression threshold (Figure 2.2a,b).  
The in-phase Ca
2+
/cAMP oscillations within the AKAP79/150 microdomains are in sharp 
contrast to the out of phase oscillations in the cytosol. To determine if the in-phase Ca
2+
/cAMP 
oscillations is a feature of membrane compartments and specific to the AKAP79/150 
microdomains, we examined the cAMP dynamics within the general plasma membrane (PM) 
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compartment. We fused the lyn kinase palmitoylation sequence to the Epac2-camps probe, 
expressed the plasma membrane targeted biosensor in MIN6 cells and stimulated the circuit 
(Wachten et al. 2010). Interestingly, we also observed unanimous, robust out-of-phase cAMP 
oscillations (lag time 47sec +/- 4sec, n=24) (Figure 2.1c). Each local peak of intracellular Ca
2+
 
(approx.. 2–4x RFP increase) corresponded to a local trough in cAMP (-5-25% FRET ratio 
change), followed by a slower reversal of both signals to a pre-stimulated baseline, suggesting 
that increasing Ca
2+
 levels are coupled with decreasing cAMP in this compartment. The stark 
contrast between cAMP dynamics at the AKAP79/150 scaffold and the general PM hints at a 
differential, spatiotemporal regulation of the oscillatory circuit and suggests that the cAMP-Ca
2+
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Figure 2.1 The phase of oscillating cAMP is shifted between the AKAP79/150 compartment and the general 
plasma membrane compartment, relative to Ca
2+
. (A) Depiction of the AKAP79 compartment and plasma 
membrane compartment, including targeted cAMP biosensor (Ci/Ce)Epac2-camps to measure the compartment-
specific cAMP signaling. Image insets show CFP fluorescence at plasma membrane for AKAP79-(Ci/Ce)Epac2-
camps (left) and lyn-(Ci/Ce)Epac2-camps (right). (scale 10um) (B) Schematic of the AKAP79-(Ci/Ce)Epac2-camps 
sensor. Pseudocolor images of a representative TEA-induced oscillating MIN6 beta cell expressing the AKAP79-
(Ci/Ce)Epac2-camps and RCaMP probes to measure AKAP-specific cAMP and cytosolic Ca
2+
, respectively. The 
cyan over yellow emission ratio is proportional to cAMP concentration and the RFP signal is proportional to Ca
2+
 
concentration. Representative single cell traces of an in-phase oscillating beta cell, whole-cell fluorescence 
measured. Purple trace is cAMP and red trace is Ca
2+




AKAP79-(Ci/Ce)Epac2-camps A B 
Pseudocolor images of a representative TEA-induced oscillating MIN6 beta cell expressing the Lyn-(Ci/Ce)Epac2-
camps and RCaMP probes to measure PM-cAMP and cytosolic Ca
2+
, respectively. The cyan over yellow emission 
ratio is proportional to cAMP concentration and the RFP signal is proportional to Ca
2+
 concentration. Representative 
single cell trace of an out-of-phase oscillating beta cell, whole-cell fluorescence measured. Purple trace is cAMP and 
red trace is Ca
2+
. (D) Cross-correlation between the oscillatory Ca
2+
 and cAMP signals from the representative in-
phase AKAP79 (blue) and out-of-phase PM (orange) beta cells from B, C. (E) Time lag (sec) between the cAMP 
and Ca
2+
 signals for the two compartments (AKAP79 blue, PM orange). Found by the taking the absolute value of 
the shortest delay yielding the maximum cross-correlation. (time lag for AKAP79/150 is 13sec ± 3sec, time lag for 














Figure 2.2 The time lag, and thus cAMP phase, depends on the expression level of AKAP79-(Ci/Ce)Epac2-
camps (A) Time lag vs. normalized YFP fluorescence (measure of relative expression of the AKAP79-targeted 
sensor by YFP acceptor) shows a positive correlation between the amount of sensor expressed and the length of time 
lag. We stratified the cells into “low” and “high” expressers by empirically defining an intensity threshold. (B) The 
observed expression dependence can be clearly seen here, were low-expressing cells displayed mostly in-phase 
cAMP oscillations (avg time lag 13s ± 3s) at AKAP79/150 while high-expressing cells tended to have longer time 




The oscillation phase is regulated by balanced activities of Ca
2+
 sensitive ACs and PDEs 
Since TEA induces continuous Ca
2+
 oscillations, to determine more precisely the temporal 
relationship between Ca
2+
 and cAMP at the general PM, we measured the impulse response of 
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the circuit to a short membrane depolarization stimulus. KCl (15mM) addition and washout was 
used to elicit a transient influx of Ca
2+
 (cite) and we observed a synchronous cAMP decrease 
(avg. -7.6% ± 0.6%, n=20)  followed by a return to baseline (Figure 2.3a). This suggested to us 
that increasing cytosolic Ca
2+
 was coupled to a decrease in PM-cAMP via Ca
2+
-sensitive AC or 
PDE activities. Ca
2+
-inhibited ACs (AC5,6) have low specific activity both in the presence and 
absence of physiological Ca
2+ 
as well as a lower distribution in the pancreas (Defer et al. 2000), 
so we turned our focus to PDEs. Expression of the Ca
2+
-dependent PDE1 family in MIN6, 
specifically PDE1C, has been implicated in modulating GSIS (Han et al. 1999). Acute addition 
of 8MM-IBMX (100uM), a relatively selective PDE1 inhibitor, effectively decoupled oscillatory 
cAMP from Ca
2+
 oscillations (n=18) (Figure 2.4a), suggesting that Ca
2+
-triggered PDE1 
activation might be mediating the transient cAMP drops. Of note, the overall increase of cAMP 
(avg. 9.8% ± 0.1%) on the slower timescale also led to an increase in the Ca2+ frequency, 
consistent with the previously identified role of cAMP/PKA in regulating the Ca
2+
 oscillation 
frequency (Ni et al. 2011). We also tested the role of two families of abundant PDEs in 
pancreatic beta cells, PDE3 and PDE4, on Ca
2+
-mediated cAMP coupling by acute 
pharmacologic inhibition after initiating the oscillatory circuit. Treating cells with milrinone 
(PDE3 inhibitor, 10uM, n=12) or rolipram (PDE4 inhibitor, 1μM, n=15) slightly increased 
cAMP levels on a slow timescale but failed to have an effect on the cAMP-Ca
2+
 coupling or the 






Figure 2.3 Impulse response of plasma membrane 
cAMP to a spike in Ca
2+
 (A) KCl-mediated 
depolarization triggers sharp Ca
2+
 entry which is coupled 
to a transient cAMP decrease (-7%). Purple trace is 
cAMP, red is Ca
2+
. 
Figure 2.4 Inhibition of the Ca
2+
-sensitive PDE1 
decouples plasma membrane cAMP from Ca
2+
 
oscillations  (A) Representative single cell trace of 
oscillating PM-cAMP. Acute inhibition of PDE1 family 
(8MM-IBMX) decouples the out-of-phase cAMP 
oscillations, leading to an abolishment of the cAMP 

















Figure 2.5 Inhibition of PDE3 and PDE4 does not decouple plasma membrane cAMP oscillations from Ca
2+
 
(A) Representative trace depicting out-of-phase PM-cAMP oscillations. Acute inhibition of PDE3 (milrinone 10uM) 
did not affect cAMP oscillations apart from a small increase on a longer time scale. Purple trace is cAMP, red is 
Ca
2+
. (B) Representative trace depicting out-of-phase PM-cAMP oscillations. Similar to A, inhibition of PDE4 






AC8 << PDE1 AC8 >> PDE1 A 
Figure 2.6 Manipulation of the relative strength 
between Ca
2+
-activatable AC8 and PDE1 is sufficient 
to describe both cAMP-Ca
2+
 phase relationships (A) 
By manipulating a parameter describing the relative 
strength of AC8 vs. PDE1 (Supp.), cAMP oscillations 
can exist as either out-of-phase or in-phase (blue trace is 
cAMP, black is Ca
2+
), in a simple well-mixed model of 
the beta cell. 
In order to gain a more quantitative understanding of the regulation of the cAMP-Ca
2+
 phase 
relationship, we extended our previous mathematical model of the beta cell circuit (Ni et al. 
2011) to include well-mixed, Ca
2+
-driven PDE and AC activity components. Kinetic parameters 
for each opposing arm were taken from the Ca
2+
-activatable PDEs and ACs including PDE1 and 
AC8, an abundant Ca
2+
-activatable transmembrane AC isoform in beta cells that has been shown 
to mediate sustained insulin secretion and associate with the AKAP79/150 scaffold (Dou et al. 
2014). By computationally manipulating the activity of each, the cAMP phase can exist as either 
out-of-phase or in-phase with respect to Ca
2+
, indicating that the phase relationship can be 
represented as a function of the relative strength between such Ca
2+
-sensitive players, echoing 
previous work (Figure 2.6a) (Peercy et al. 2015; Fridlyand et al. 2007). According to the model, 
increasing the relative contribution of AC8, for example by increasing the concentration of AC8, 
can change the cAMP-Ca
2+








To test this prediction, we first turned our attention to oscillatory cAMP at the general PM and 
overexpressed full-length AC8. Interestingly, we found that AC8 overexpression reversed the 
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A B Lyn-(Ci/Ce)Epac2-camps, + AC8 (1000ng) 
cAMP-Ca
2+
 phase relationship in a titratable regime where the percentage of in-phase oscillating 
cells correlated with increasing amounts of the cotransfected AC8 (0 – 1000ng AC8 transfected, 
n=56) (Figure 2.7a,b). This demonstrates that higher AC8 levels are sufficient to reverse the 
cAMP phase at the PM in the presence of TEA-stimulated, global Ca
2+
 oscillations.  
Furthermore, overexpression of extremely low amounts of AC8 (50ng transfected) was also 
sufficient to reverse the cAMP phase at highly-expressed AKAP79/150 (500ng transfected) 
compartments (out-of-phase to in-phase, monitored by highly-expressed AKAP79-Epac2-
camps), hinting at a unique AKAP79/150-centric sensitivity to AC8 perhaps due to their 








Figure 2.7 Supplementing beta cells with AC8 is sufficient to reverse the plasma membrane cAMP phase (A) 
Representative trace from oscillating beta cell depicting PM-cAMP in the presence of co-transfected AC8 (1000ng). 
Overexpression of AC8 is sufficient to elicit in-phase cAMP oscillations at the PM. Purple trace is cAMP, red is 
Ca
2+
. (B) A dose-dependent relationship was observed where more AC8 transfected corresponded to responding 




AKAP79-(Ci/Ce)Epac2-camps (high), +AC8 
Figure 2.8 cAMP oscillations are in-phase around 
high-expressing AKAP79 cells when minimal 
amounts of AC8 are cotransfected (A) In cells highly 
expressing the AKAP79-cAMP sensor (500ng 
transfected), all cells oscillate with in-phase cAMP upon 
the cotransfection of a minimal amount of AC8 (50ng) 







To elucidate the role of the Ca
2+
-activatable AC/PDE balance and cAMP-Ca
2+
 phase relationship 
within the AKAP79/150 compartment, we measured the KCl-induced impulse response here as 
we had done previously for PM-cAMP, and observed a synchronous, small rise in cAMP (3.0% 
± 1.8%, n=12) upon the sharp influx of Ca2+ (Figure 2.9a). This striking difference compared to 
the PM-cAMP impulse response further highlights the AKAP79/150 compartment as kinetically 
distinct from the general PM. According to the math model, decreasing the relative contribution 
of AC8 would shift the cAMP-Ca
2+
 phase relationship from in-phase to out-of-phase, as the 
relative contribution from Ca
2+
-triggered PDE1 increases. To test this prediction, we first 
knocked-down endogenous AC8 in the MIN6 cells (Raoux et al. 2015) and observed most cells 
exhibited out-of-phase cAMP oscillations at the AKAP79/150 compartment (n=11) (Figure 
2.10a), indicating an AC8-specific role in mediating the cAMP-Ca
2+
 phase signature. 
Additionally, we overexpressed full-length PDE1C to tilt the AC8/PDE1 balance and found this 
perturbation was also sufficient to drive more cells to elicit out-of-phase cAMP at AKAP79/150 




Figure 2.9 Impulse response of AKAP79 cAMP to a 
spike in Ca
2+
 (A) KCl-mediated depolarization triggers 
sharp Ca
2+
 entry which is coupled to a transient cAMP 




A B AKAP79-(Ci/Ce)Epac2-camps, +shAC8 AKAP79-(Ci/Ce)Epac2-camps, +PDE1C 
cAMP-Ca
2+
 phase relationship is representative of a sensitive, compartmentalized balance 
between the Ca
2+












Figure 2.10 cAMP phase reversal at AKAP79/150 compartment by knocking down AC8 or overexpressing 
PDE1C (A) By knocking-down AC8, the cAMP phase at AKAP79/150 is reversed from mostly in-phase cells to 
out-of-phase, as seen in this representative cell trace. Purple is cAMP, red is Ca
2+
. (B) Phase reversal at 
AKAP79/150 can also be seen if PDE1C is overexpressed, further illustrating the connection between the cAMP-
Ca
2+
 phase relationship and the fine balance between Ca
2+






AC8 and the AKAP150 scaffold are localized in nanoclusters at the membrane 
Both AC8 and AKAP79/150 are membrane-localized and associate with each other in beta cells 
(Willoughby et al. 2010) while PDE1 isoforms are found in the cytoplasm (Bender et al. 2006; 
Goraya et al. 2008). We sought to better understand the role of this differential localization of 
Ca
2+
-driven cAMP sources and sinks in the context of the cAMP-Ca
2+
 phase relationship. The 
close spatial juxtaposition between the AKAP79/150 and general PM compartments presents a 
significant challenge for cAMP compartmentation where cAMP oscillations are distinctly 
regulated within these adjacent microdomains. Indeed how is cAMP, as a rapidly diffusing small 
molecule, spatially compartmentalized in cells is not clearly understood (ref), especially given 
the low catalytic efficiency of single cAMP producing and degrading enzymes. Based on our 
previous finding that AKAP79 form nanoclusters on the plasma membrane, we hypothesize that 
AC8, possibly with the help of AKAP150, form nanoclusters on the plasma membrane of MIN6 
cells to compartmentalize cAMP. To test this hypothesis, we took a closer look at the spatial 
organization of AC8 and AKAP150 at the membrane. In order to investigate the nanoscale 
architecture at the PM, we utilized STORM microscopy in TIRF to obtain a super-resolved view 
of each protein. We found the AKAP150 scaffold was organized in clusters with a mean 
diameter of 148nm ± 8nm (n=9) (Figure 2.11a-c), consistent with many recent reports 
demonstrating AKAP79/150’s tendency to cluster/multimerize in other cell types (Zhang et al. 
2016; Tajada et al. 2017, Mo et al. 2017, Purkey et al. 2018). This suggested to us that the 
AKAP79/150 compartment-specific cAMP phase is representative of the balanced cAMP 
generation and degradation within these AKAP clusters. Due to the known interaction between 
AKAP79 and AC8, next we probed the spatial organization of AC8. We found AC8 also 
distributes non-uniformly at the PM and clusters more strongly than AKAP150, with a tighter 
39 
 
A B C 
AC8 AKAP150 
AC8 AKAP150 
mean diameter of 106nm ± 2nm and an average nearest-neighbor spacing of 296nm between 
cluster centers (n=7) (Figure 2.11b,c). This difference in cluster size might be due to a higher-
order structure of the co-organized AKAP150 and AC8, and more work will need to be done to 
probe this. With the evidence of the nanoscale organization of AKAP150 and AC8 on the plasma 
membrane, we further hypothesized that the increased spatial density of Ca
2+
-driven cAMP 
sources within the AKAP150 clusters is important in compartmentalizing cAMP production and 




Figure 2.11 Super-resolution STORM images of AKAP150 and AC8 at the surface of MIN6 beta cells 
indicate both proteins cluster (A) Super-resolved image of AKAP150 (Alexa647) showing clustering of the 
scaffold. Scale 10μm, inset 500nm. (B) Super-resolved image of AC8 (Alexa647) showing clustering of the Ca
2+
-
sensitive AC. Scale 10μm, inset 500nm. (C) Ripley-K analysis measures the average radii of clusters, and indicates 








 phase relationship is modulated by AKAP150:AC8 clustering 
In order to probe the role of AKAP79/150:AC8 clustering in the cAMP-Ca
2+ 
phase relationship, 
we sought to build a mathematical framework to describe the compartmentalization. We adapted 
a 2D reaction-diffusion model (Haselwandter et al. 2015) to construct a minimal experimental 
system with AKAP79/150 and AC8 at the PM. Briefly, the attractive interactions between 
AKAP79/150, itself, and AC8, coupled with diffusion, can create a positive feedforward loop 
and stabilize spatial patterning of AKAP79/150:AC8 within clusters at the membrane (Supp.). 
We then tuned the model and optimized parameters using the AC8 STORM cluster 
measurements (106nm diameter, 296nm nearest-neighbor distance). To connect the clustering 
with the Ca
2+
-cAMP-PKA oscillatory circuit, we used the 2D steady-state AKAP79/150:AC8 
pattern (Figure 2.12a) as the upper boundary in a model volume and selected a simple prism 
domain (400nm x 400nm x 600nm) centered about one AKAP79/150:AC8 cluster for our 
simulations. We extended the previous well-mixed beta cell model to include a 3D spatial 
component with cAMP diffusion (60μm
2
/s). By having AC8 within the AKAP79/150:AC8 
clusters on the PM face and PDE1 well-mixed throughout the volume, we could describe Ca
2+
-
driven cAMP oscillations that were in-phase within the immediate vicinity of a cluster, but 
sharply transitioned out-of-phase outside the cluster (>250nm from center) (Figure 2.12b). 
Unsurprisingly, the regime that recapitulates this phase relationship is sensitive to the spatially-


























 phase relationship can be described by a 3D reaction-diffusion model involving co-
clusters of AKAP79/150 and AC8 (A) 2D Reaction-diffusion steady state depicting co-clustering of AKAP79/150 
and AC8. (B) 3D reaction-diffusion model of a single co-cluster positioned at the PM in the beta cell, taken from the 
2D steady state, in a 400nm cubic volume. cAMP oscillates in-phase immediately within an AKAP79/150:AC8 co-
cluster due to the high effective concentration of AC8, but out-of-phase at the PM or cytosol due to the presence of 










Figure 2.13 Disturbance of the AKAP150:AC8 
interaction is predicted to reverse the cAMP phase 
relationship at AKAP79/150 nanodomain (A) The 
spatial transition from in-phase to out-of-phase cAMP 
(in-phase oscillations have a lower phase shift, as 
measured by a period-normalized time lag) is sharp due 
to cAMP diffusion and the difference in AC8/PDE1 
distributions (blue trace). Disruption of the interaction 
between AKAP150 and AC8 promotes a loss of in-phase 
cAMP at AKAP79/150 due to a lower co-localized 
effective concentration of AC8. 
According to the model, weakening the interaction between AC8 and AKAP79/150 diminishes 
the reinforcing loop and impairs cluster stabilization. Without the high local concentration of 
AC8 driving a net positive cAMP production within an AKAP79/150 cluster, cAMP is predicted 
to oscillate out-of-phase with Ca
2+
 regardless of PM location (Figure 2.13). To test this 
prediction, we overexpressed the amino terminus of AC8 (AC8
1-106
) required for interaction with 
AKAP79/150 (Willoughby et al. 2010) in order to compete off endogenous AC8 from the 
endogenous AKAP150 scaffold. The disruption of the AC8-AKAP150 interaction was validated 
by transiently transfecting EGFP-tagged AC8
1-106
 in MIN6 and performing proximity ligation 
assay (PLA). Compared to non-transfected cells, cells expressing the AC8
1-106
 peptide had a 39% 
± 4% reduction in the number of PLA signals, indicating a decrease in the number of 
AKAP150:AC8 interactions (Figure 2.14a). By measuring AKAP79/150-localized cAMP in the 
presence of AC8
1-106
, we observed a significant increase in the average lag time (43sec ± 6sec, 
n=33) due to a higher percentage of cells exhibiting out-of-phase cAMP oscillations, indicating 
that the AKAP79/150:AC8 competitor peptide was sufficient in reversing the phase relationship 
in the AKAP79/150 compartment. In addition, this nanoscale perturbation establishes the 
regulatory role of the AKAP79/150:AC8 interaction in mediating the compartmentalized cAMP-
Ca
2+


























Figure 2.14 Disrupting AKAP79/150:AC8 interaction reverses the cAMP phase in the AKAP79/150 
compartment (A) PLA on MIN6 in the presence and absence of EGFP-tagged AC8
1-106
. Representative images, 
showing less PLA puncta signal in cells expressing the AC8
1-106
 disruptor peptide (scale 10μm). In cells expressing 
the peptide, there’s on average 38% less puncta per cell compared no non-expressing (p<0.05). Negative controls 
where one antibody is used shows minimal signal per cell. (B)  Disruption of the AKAP79/150:AC8 interaction 
lengthens the time lag between the cAMP and Ca
2+
 signals at the AKAP79/150 compartment (avg time lag in 
absence of disruptor is 13sec ± 3sec, and presence of disruptor 43sec ± 6sec) (p<0.05). This is due to more cells 
displaying out-of-phase cAMP oscillations here, as evidenced in the shown representative cell trace. Purple is 





AKAP79/150-mediated phase relationship modulates oscillatory Ca
2+
   
Oscillatory Ca
2+
 influx lies upstream of many important processes of the pancreatic beta cells 
such as pulsatile insulin secretion, transcriptional regulation, and metabolic homeostasis 
(Bertram et al. 2011). Multiple feedback mechanisms whereby cAMP modulates Ca
2+ 
have been 





the context of the spatial compartmentalization of the phase relationship at AKAP79/150. Due to 
the modulatory role of PKA in the Ca
2+
-cAMP-PKA oscillatory circuit and the presence of PKA 
at AKAP79/150, we wanted to know how in phase cAMP oscillations with respect to Ca
2+
 are 
translated into PKA activities and if spatial compartmentalization of the phase relationship is 
also maintained at the PKA activity level. To this end, we fused our biosensor for PKA activity 
(AKAR4) (Depry et al. 2011) to either full-length AKAP79 or the PM-targeting motif and 
expressed the sensors in MIN6 cells. Upon TEA stimulation, PKA activity was observed to 
oscillate in-phase at the AKAP79/150 compartment (n=6) but out-of-phase at the general PM 
(n=23) (Figure 2.15a,b), indicating that the compartmentalized phase relationship is preserved 







Figure 2.15 The phase of PKA activity is also compartmentalized between AKAP79/150 and the general 
plasma membrane (A) By fusing full-length AKAP79 to the genetically encoded reporter of PKA activity, 
AKAR4, we found PKA activity also oscillated in-phase at the AKAP79/150 nanodomain, echoing the in-phase 
cAMP dynamic with perhaps a slightly longer time lag. Shown here is a representative trace, black is PKA activity 
and red is Ca
2+
. (B) PKA activity at the general PM oscillates out-of-phase, as does PM-cAMP, as measured by 
targeting AKAR4 to the PM with the lyn sequence. Shown here is a representative trace, black is PKA activity, red 
is Ca
2+




Spatiotemporal organization of PKA signaling and its phosphorylation targets via AKAPs have 
been implicated in regulating several important pathways. For example, PKA has been shown to 
phosphorylate CaV1.2 in an AKAP79/150-dependent manner and this modification can influence 
the open probability of the channel (Murphy et al. 2014), suggesting a mechanistic link between 
local cAMP/PKA activity and global oscillatory Ca
2+
. Thus, we sought to study the functional 
role of the spatially-compartmentalized cAMP-Ca
2+





 oscillations (monitored by RCaMP) were stimulated either in the presence 
of the EGFP-tagged AKAP79/150:AC8 disruptor peptide, AC8
1-106
, to reverse the phase at the 
AKAP79/150 compartment, or EGFP alone as a control. Interestingly, we found that the 
expression of the disruptor peptide was correlated with a significant decrease in the peak ratio 
between the second Ca
2+
 peak and the first Ca
2+
 peak (control avg. -1.6%, n=270; AC8
1-108
 avg. -
10.8%, n=562), post TEA addition, hinting at impaired Ca
2+
 entry for sustained oscillations 
(Figure 2.16a). In addition to intracellular Ca
2+
 concentration, the precise timing of internal 
oscillatory events is theorized to be under the control of a master “pacemaker” circuit critical for 
modulating the cell’s functions, such as glucose homeostasis and pulsatile insulin secretion 
(Fridlyand et al. 2010). In the presence of the disruptor peptide, cells exhibited a longer elapsed 
time between oscillatory Ca
2+
 peaks (control avg. 3.9min ± 0.1min, n=270; AC81-108 avg. 4.6min 
± 0.1min, n=562), suggesting that the timing of the pacemaker circuit was disturbed (Figure 
2.16b). In addition to the precise timing, the regularity of cytoplasmic Ca
2+
 in beta cells is crucial 
in mediating pulsatile insulin secretion from the pancreas (Gilon et al. 2002). By stratifying the 
disruptor peptide-expressing cell population into “low” and “high” expressers, and performing a 
blinded classification of responding cells based on the regularity of the Ca
2+
 oscillation, we 
found a positive correlation between the percentage of cells exhibiting irregular oscillations and 
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the expression level of the disruptor peptide (42% for EGFP “none” control vs. 68% for high-
expressing AC8
1-108
 disruptor) (Figure 2.16c). Taken together, these data signifies that the 
compartmentalized cAMP-Ca
2+
 phase relationship regulates the oscillatory Ca
2+
 signal and  plays 
an important role in determining the pace, regularity and sustainability of the Ca
2+










 oscillatory dynamics are affected by expression of the disruptor peptide in beta cells (A) The 
ratio between the second and first Ca
2+
 peaks in a TEA-stimulated beta cell is reduced (~90%) in the presence of the 
AKAP79/150 disruptor peptide, a hallmark of transient oscillations. (B) The time between the Ca
2+
 oscillatory peaks 
is also lengthened (avg. ~30sec) when the disruptor peptide is expressed. (C) Higher expression of the disruptor 
peptide correlates with a greater percentage of cells exhibiting irregular Ca
2+




The phase in an oscillatory signaling circuit, like the amplitude and frequency, represents yet 
another mode of informational encoding which itself can be regulated spatially. Pancreatic beta 
cells provides a striking example of this regulation for the Ca
2+
-cAMP-PKA circuit where the 
A C B 
47 
 
oscillatory cAMP/PKA phase relative to Ca
2+
 is distinctly regulated within plasma membrane 
compartments through intracellular organization of scaffolds and signaling effectors. Localized 
perturbation of this spatial phase signature disrupts global Ca
2+
 oscillations and thus has far-
reaching consequences on the functional landscape of the beta cell. 
Despite the enhanced understanding gained by the utilization of genetically encoded biosensors, 
careful consideration must be taken when monitoring compartmentalized signals. Expressing 
sensors fused to a protein-of-interest for localized signaling interrogation can disrupt native 
signaling pathways, both globally and locally, and thus such experiments require proper controls. 
For example, we observed that the AKAP79/150-centric cAMP phase not only differed from the 
cAMP phase at the general PM, but also depended on the absolute amount of the fused sensor 
present in each cell (cells with more expressed fused sensor correlated with AKAP-localized out-
of-phase cAMP). Although AKAP79/150 has not been found to possess intrinsic enzymatic 
activity (Gold et al. 2011), we still checked for such an overexpression effect of the scaffold 
protein alone by monitoring PM-cAMP in cells overexpressing AKAP79 and found all cells 
exhibited out-of-phase cAMP (data not shown). More than likely, the sensor expression 
dependence was due to an over-abundance of the AKAP79/150 scaffold relative to other key 
assembly constituents such as AC8, and thus the stoichiometry of the signaling complex was not 
preserved (Levchenko et al. 2000). This was conveyed by the sensitivity of the cAMP phase to 
the balance between AC8/PDE1, as well as how “reconstitution” of the signaling complex at the 
highly-expressed AKAP79/150 scaffold by cotransfection of a minimal amount of AC8 retrieved 
the AKAP79/150-localized in-phase cAMP-Ca
2+
 phase relationship (Figure 2.8a). Along these 
same lines, compartmentalized kinetics of signaling complexes depend on the presence or 
absence of key interaction partners, and thus signaling roles may differ depending on the context 
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or cell type. For example, AKAP79/150 has been shown to locally potentiate PKA signaling 
differently in neurons, neonatal rat ventricular myocytes, and pancreatic beta cells here, all using 
a similar AKAP79-AKAR construct to highlight the compartmentalized activity (Oliveria et al. 
2003; Musheshe et al. 2018). 
Compartmentalization of cAMP/PKA signaling is instrumental in processing a diverse set of 
inputs and mediating specific cellular functions; however, the mechanistic details of 
compartmentalization are still largely unresolved (Mesheshe et al. 2018). Given the measured 
kinetic rates of most ACs and PDEs, coupled with fast diffusion of the small cAMP molecule, 
the generation of local cAMP gradients around single enzymes is unmaintainable (Conti et al. 
2014). Context-dependent discrepancies in some of the kinetics (ie. differences of in vitro versus 
in vivo measurements) or slower cAMP diffusion due to buffering have been proposed as 
potential compartmentalizing mechanisms (Agarwal et al. 2016). Here we propose that the 
nanoscale organization of key cAMP effectors and regulators, specifically the relative spatial 
arrangement of ACs and PDEs, coupled to a global stimulus, might also play an important role in 
the localization of cAMP signaling. Despite the slow rates measured for individual ACs, we 
computationally and experimentally describe conditions in which the generation of 
compartmentalized cAMP can emerge from the clustering of many AC8 enzymes at the 
membrane and bulk distribution of PDE1 in the cytoplasm. Although clustering of PDEs have 
been proposed as a potential localization mechanism for cAMP (Lohse et al. 2017), this is the 
first demonstration of AC clustering and a functional importance in maintaining this 
organization, to the best of our knowledge. Additionally, this system also serves as a general 
demonstration of how a cell can translate a diffuse, global signal (Ca
2+
) into a compartmentalized 
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signal (cAMP) by local activation and global inhibition, a strategy that is likely utilized in many 
other cellular contexts. 
The functional consequences of reversing the compartmentalized cAMP phase at AKAP79/150 
on intracellular Ca
2+
 oscillations suggests a possible mechanism of the Ca
2+
-cAMP-PKA 
oscillatory circuit as a modulator of the pacemaker circuit in beta cells (Fridlyand et al. 2010), 
disruption of which is a hallmark of type 2 diabetes (Schmitz et al. 2002). AKAPs have been 
shown to compartmentalize and enrich cAMP/PKA signaling in many other cellular processes 
(Dell’Acqua et al. 2006, Mo et al. 2017) and several AKAP79/150-associated signaling effectors 
and pathways are sensitive to AKAP79-anchored PKA and potentiate Ca
2+
 dynamics, such as 
regulation of voltage-mediated Ca
2+
 entry via PKA-dependent phosphorylation of CaV1.2, the 
modulation of store-operated Ca
2+
 entry by both PKA-dependent STIM1 and Orai1 
phosphorylation (Murphy et al. 2014; Thompson et al. 2015; Zhang et al. 2019). Additional 
levels of regulatory feedback within the oscillatory circuit have also been proposed, such as a 
negative feedback loop between PKA and AC8 (Willoughby et al. 2012). Future research will 
further dissect which PKA targets are involved in decoding the information embedded in the 
local phase control. Aside from AKAP79/150-dependent regulation of the global Ca
2+
 signal, 
localized cAMP/PKA signaling at the AKAP79/150 scaffold might also play a role in regulating 
downstream insulin secretion due to close interactions between AKAP79/150 and the insulin 
secretory granules via CaV1.2 (Barg et al. 2001). Several important components and processes of 
the secretory machinery have been identified as targets of cAMP/PKA signaling here, such as 
PKA-dependent mobilization of granules (Renstrom et al. 2004) and modulation of 
synaptosomal protein SNAP25 (Gao et al. 2016), as well as control of fusion pore formation by 
cAMP-dependent Epac (Gucek et al. 2018). As we have shown, compartmentalized cAMP/PKA 
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signaling at the AKAP79/150 macromolecular complex is exquisitely-tuned and disruption of 
this spatiotemporal coordination is associated with functional repercussions. 
The Ca
2+
-cAMP-PKA oscillatory circuit in pancreatic beta cells integrates many important 
regulators of cellular function, and the precise coordination of each is required for proper 
signaling control. Here we have uncovered a spatiotemporal organization of the circuit where the 
oscillatory phase between cAMP/PKA and Ca
2+
 depend on the spatial proximity of the 
AKAP79/150 scaffold protein. The construction principles of this signaling nanodomain, 
including the dependence on spatial clustering of sinks and sources, are likely generalizable to 













Supplemental – Modeling (from M. Getz) 
Well mixed system 
Let us then consider the network shown in Figure 2.17. This network has been shown to exhibit 
oscillations due to the action of PKA on IP3 receptors and KATP plasma membrane channels. But 
this network is not easily solved analytically due to its various feedback. We therefore propose a 
simple model to allow discerning of solutions that allow in- and out-of-state solutions. 
 
Figure 2.17 The full system network for PKA mediated Ca-cAMP oscillations. 
Simplified model 
Consider the following system, where S is the stimulus (𝐶𝑎2+), A is an activator (AC), B is an 




The system is in a state that the change in R allows for S influx in a semi predictable manner. 
Therefore for this system is deemed to be stable there exists an 𝑆0 that give the stable solution 
𝑅0. All constants must be positive to remain physical. There exists a constant independent source 
and sink within the system. The S dependent source is localized heterogeneously on the 
membrane, the independent source is located homogeneously, and both sinks are located 
uniformly in the cytosol. 
Governing Equations 
For simplicity, let both 𝐴 and 𝐵 be linear functions of 𝑆 of the linear form 𝑎𝑆 + 𝑏. The well-
mixed function of R is then, 
𝑑𝑅
𝑑𝑡
= 𝑣1(𝑎1𝑆 + 𝑏1) − 𝑣2(𝑎2𝑆 + 𝑏2)𝑅 + 𝑣𝑖𝑝 − 𝑣𝑖𝑑𝑅 
Numerical implementation 
Well mixed system results were solved and analyzed in MATLAB. FEM simulations were 
performed in COMSOL and analyzed in MATLAB. 
Well-mixed/analytic solutions 
To analyze if the system lies in an in- or out-of-phase state we find the direction of the system 
change after initialization to 𝑆0 (i.e. the basal stimulus). First we must solve for 𝑅0, we find: 
𝑅0 =
𝑣1(𝑎1𝑆0 + 𝑏1) + 𝑣𝑖𝑝
𝑣2(𝑎2𝑆0 + 𝑏2) + 𝑣𝑖𝑑
 
We then allow a pulse of 𝑆 from 𝑆0 to 𝑆ℎ, akin to VGCC opening allowing Ca flux. Therefore 
solving for the sign of R we see: 
𝑑𝑅
𝑑𝑡
= 𝑣1(𝑎1𝑆ℎ + 𝑏1) + 𝑣𝑖𝑝 − (𝑣2(𝑎2𝑆ℎ + 𝑏2) + 𝑣𝑖𝑑)
𝑣1(𝑎1𝑆0 + 𝑏1) + 𝑣𝑖𝑝




(𝑣1𝑎1(𝑣2𝑏2 + 𝑣𝑖𝑑) − 𝑣2𝑎2(𝑣1𝑏1 + 𝑣𝑖𝑝))(𝑆ℎ − 𝑆0)
𝑣2(𝑎2𝑆0 + 𝑏2) + 𝑣𝑖𝑑
 
Since we only care about the sign we can then characterize the solution by 
𝑣1𝑎1(𝑣2𝑏2 + 𝑣𝑖𝑑)
𝑣2𝑎2(𝑣1𝑏1 + 𝑣𝑖𝑝)






< 1 out of phase
 




Although our system does show the ability to oscillate in and out of phase in a well behaved 
manner, this will not help if a uniform system is present. Therefore when moving to a 3D spatial 
map we must consider how two solution regimes can be recovered. Experimental data suggests 
that AKAP oligomerizes [Gao2011,Gold2010] forming up to tetrameric structures. This should 
allow spatial instabilities like those seen in [Haselwandter et al.] used to describe post synaptic 
domains. 
Methods 
Construction of reaction network 
A biochemical network was constructed to allow previously shown interactions within 𝛽-cells, 
after the depolarization event. The computational model took into consideration of multiple 
channels; calcium, potassium, Leaky, and calcium sensitive potassium (Table [table:V]). Most 
importantly were the included feedback of PKA with KATP channels and inclusion of Ca2+-
sensitive ACs and PDEs. The model contains X parameters with Y free parameters, values are 
constrained through both previously peer reviewed publication results and new experimental 
results using FRET. AC and PDE data was collected from related isoforms. 
We assumed signaling components were present in large enough quantities such that 
concentration changes were smooth and in a deterministic fashion. The well mixed model is 
comprised of only one compartment in which the conversion factors are assumed to be absorbed 
into the kinetic rate constants. 
The network of interactions was constructed using COPASI (http://www.nrcam.uchc.edu, 
http://copasi.org/). The model was built in COPASI to leverage the inbuilt fitting techniques for 
initial guesses. The COPASI platform has built-in capabilities to conduct dynamic sensitivity 
analysis, which is an important aspect of dynamic systems modeling. 
Turing patterns for generation of heterogeneity 
A biochemical network showcased in [Christoff] was recreated using a finite element solver, 
COMSOL Multiphysics5.4 (Build:295), on a 1.6𝜇mx1.6𝜇m domain under the assumption of an 
independent time scale from the reaction kinetics after depolarization. We then modified the 
system to allow two receptor contributions (AC and VGCCs) and tuned connectivity (mostly 
parameters 𝛽 and 𝜇) such that similar patterns arose to what is observed in STORM imaging. For 
accuracy an extra fine mesh was used and periodic boundary conditions allowed for an 
assumption of a larger field of values existing. 
Simulations of the full spatial systems 
The well mixed network was imported into COMSOL Multiphysics5.4 (Build:295), to solve with 
in-homogenous boundary conditions. For computational simplification variations were 
performed with a Gaussian profile on the top boundary, the size of the domain and gaussian 
profile were informed by STORM images. The system is a 0.4x0.4x0.6 𝜇m rectangle with 
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periodic boundary conditions in the z planes. The top plane is assumed to be the membrane and 
the bottom is a no flux condition. For the membrane plane a Gaussian profile normalized such 
that the average value is 1𝜇M (conversion to plane coord). The Ca2+ sensitive AC initial 
conditions (Gaussian profile) is fixed by setting diffusion to ≈0. This assumption is made 
through the statement that the patterns generated are pre-existing and not effected by the 
signaling event. 
Comparisons to experimental data 
Raw FRET data was used for model refinement. The data is compared for oscillation time and 
phase, with expected concentration change falling in the sensors sensitive range of≈0.1-1𝜇M of 
cAMP. Voltage gated channel sensitivities were not tuned, and only connection strengths 
between CaM to ACs and PDEs, which are largely less constrained in comparison, were varied.  
Model validation and predictions 
The model was validated on predictions to concentration perturbations (AC, PDE, etc.) and 
disruption of patterning (AC binding disruption) and their changes to the phase of the signal. 
Reaction tables 








 & 𝐶𝑚=5.3 pF & Ni,NatCellBio 
2 & 𝐼𝐶𝑎 = 𝑔𝐶𝑎𝑚∞(𝑉 − 𝐸𝐶𝑎) & 𝑔𝐶𝑎=600 pS, 𝐸𝐶𝑎=100 mV & Ni,NatCellBio 
3 & 𝑚∞ =
1
2
(1 + 𝑡𝑎𝑛ℎ (
𝑉−𝑣1
𝑣2
)) & 𝑣1=-20 mV, 𝑣2=24 mV & Ni,NatCellBio 







 & 𝜙=35 
1
𝑠
 & Ni,NatCellBio 






 & 𝑣3=-16 mV 𝑣4=11.2 mV & Ni,NatCellBio 
7 & 𝐼𝐿 = 𝑔𝐿(𝑉 − 𝐸𝐿) & 𝑔𝐿=150 pS, 𝐸𝐿=-75 mV & Zhang 
8 & 𝐼𝐾𝐶𝑎 = 𝑔𝐾𝐶𝑎
𝐶𝑎
𝐶𝑎+𝐾𝐾𝐶𝑎




LLLLL # & Reaction & Reaction flux & Kinetic Parameters & Ref. 
 
9 & → Ca & 𝑗Ca𝑉(1 + 𝑘PKA𝑉[PKA]) + 𝑗Ca𝐼 & 𝐶𝑚=5.3 pF & Ni,NatCellBio 
10 & 2Ca + CaM ↔ Ca2CaM & 𝑘𝑓[Ca][CaM] − 𝑘𝑟[Ca
2CaM] & 𝑘𝑓=3.6 𝑠




11 & Ca + Ca2CaM ↔ Ca3CaM & 𝑘𝑓[Ca][Ca
2CaM] − 𝑘𝑟[Ca
3CaM] & 𝑘𝑓=11 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=195 𝑠
−1  
12 & Ca + Ca3CaM ↔ Ca4CaM & 𝑘𝑓[Ca][Ca
3CaM] − 𝑘𝑟[Ca
4CaM] & 𝑘𝑓=59 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=500 𝑠
−1  
13 & AC + Ca2CaM ↔ CaM⋅AC & 𝑘𝑓[AC][Ca
2CaM] − 𝑘𝑟[CaM ⋅ AC] & 𝑘𝑓=1.7 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=10 𝑠
−1  
14 & CaM⋅AC + 2Ca ↔ AC* & 𝐾𝑐𝑎𝑡
[Ca][CaM⋅AC]
Ca+𝐾𝑚
− 𝑘𝑟[AC*] & 𝐾𝑐𝑎𝑡=59.5 𝑠
−1, 𝐾𝑚=0.1 𝜇𝑀, 
𝑘𝑟=10 𝑠
−1  
15 & PDE + Ca2CaM ↔ CaM⋅PDE & 𝑘𝑓[PDE][Ca




16 & CaM⋅PDE + 2Ca ↔ PDE* & 𝐾𝑐𝑎𝑡
[Ca][CaM⋅PDE]
Ca+𝐾𝑚




17 & PDE + Ca4CaM ↔ PDE* & 𝑘𝑓[PDE][Ca
4CaM] − 𝑘𝑟[PDE*] & 𝑘𝑓=435 𝑠
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18 & → cAMP & 𝑘𝑏𝑎𝑠𝑒([CaM ⋅ AC] + [AC]) + 𝑘𝑎𝑐𝑡[AC*] & 𝑘𝑏𝑎𝑠𝑒=0.1 𝑠
−1, 𝑘𝑎𝑐𝑡=0.785 𝑠
−1 






 & 𝑘𝑏𝑎𝑠𝑒=2 𝑠
−1, 𝐾𝑚= 0.6 𝜇𝑀 
𝑘𝑎𝑐𝑡=20 𝑠
−1 
20 & cAMP→ & 𝑉𝑖𝑛𝑑
[cAMP]
[cAMP]+𝐾𝑚
 & 𝑉𝑖𝑛𝑑=2.5 𝜇𝑀 ⋅ 𝑠
−1, 𝐾𝑚= 1.4 𝜇𝑀  
21 & cAMP + R2 → R2𝑏 & 𝑘𝑓[cAMP][R2] − 𝑘𝑟[R2𝑏] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=0.00033 𝑠
−1 & 
McCulloch 
22 & cAMP + R2𝑏 → R2𝑏𝑎 & 𝑘𝑓[cAMP][R2𝑏] − 𝑘𝑟[R2𝑏𝑎] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=0.00105 
𝑠−1 & McCulloch 
23 & cAMP + R2𝑏 → R2𝑏𝑏 & 𝑘𝑓[cAMP][R2𝑏] − 𝑘𝑟[R2𝑏𝑏] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=0.00132 
𝑠−1 & McCulloch 
24 & cAMP + R2𝑏𝑎 → R2𝑏𝑏𝑎 & 𝑘𝑓[cAMP][R2𝑏𝑎]− 𝑘𝑟[R2𝑏𝑏𝑎] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=0.0013 
𝑠−1 & McCulloch 
25 & cAMP + R2𝑏𝑏 → R2𝑏𝑏𝑎 & 𝑘𝑓[cAMP][R2𝑏𝑏] − 𝑘𝑟[R2𝑏𝑏𝑎] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.00103 𝑠
−1 & McCulloch 
26 & cAMP + R2𝑏𝑏𝑎 → R2𝑏𝑏𝑎𝑎 & 𝑘𝑓[cAMP][R2𝑏𝑏𝑎]− 𝑘𝑟[R2𝑏𝑏𝑎𝑎] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.0114 𝑠
−1 & McCulloch 
27 & PKA + R2 → R2C & 𝑘𝑓[PKA][R2] − 𝑘𝑟[R2C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=1.26E-7 𝑠
−1 & 
McCulloch 
28 & PKA + R2𝑏 → R2𝑏C & 𝑘𝑓[PKA][R2𝑏]− 𝑘𝑟[R2𝑏C] & 𝑘𝑓=1 𝑠







LLLLL # & Reaction & Reaction flux & Kinetic Parameters & Ref. 
 
29 & PKA + R2𝑏𝑎 → R2𝑏𝑎C & 𝑘𝑓[PKA][R2𝑏𝑎]− 𝑘𝑟[R2𝑏𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=3.4E-6 
𝑠−1 & McCulloch 
30 & PKA + R2𝑏𝑏𝑎 → R2𝑏𝑏𝑎C & 𝑘𝑓[PKA][R2𝑏𝑏𝑎] − 𝑘𝑟[R2𝑏𝑏𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.000936 𝑠
−1 & McCulloch 
31 & PKA + R2𝑏𝑏𝑎𝑎 → R2𝑏𝑏𝑎𝑎C & 𝑘𝑓[PKA][R2𝑏𝑏𝑎𝑎]− 𝑘𝑟[R2𝑏𝑏𝑎𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.645 𝑠
−1 & McCulloch 
32 & cAMP + R2C → R2𝑏C & 𝑘𝑓[cAMP][R2C] − 𝑘𝑟[R2𝑏C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.000659𝑠
−1 & McCulloch 
33 & cAMP + R2𝑏C → R2𝑏𝑎C & 𝑘𝑓[cAMP][R2𝑏C] − 𝑘𝑟[R2𝑏𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.0142𝑠
−1 & McCulloch 
34 & cAMP + R2𝑏𝑎C → R2𝑏𝑏𝑎C & 𝑘𝑓[cAMP][R2𝑏𝑎C]− 𝑘𝑟[R2𝑏𝑏𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.358𝑠
−1 & McCulloch 
35 & cAMP + R2𝑏𝑏𝑎C → R2𝑏𝑏𝑎𝑎C & 𝑘𝑓[cAMP][R2𝑏𝑏𝑎C]− 𝑘𝑟[R2𝑏𝑏𝑎𝑎C] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=7.84𝑠
−1 & McCulloch 
36 & PKA + R2𝑏C → R2𝑏C2C & 𝑘𝑓[PKA][R2𝑏C] − 𝑘𝑟[R2𝑏C2] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.00324 𝑠
−1 & McCulloch 
37 & PKA + R2C → R2C2 & 𝑘𝑓[PKA][R2C]− 𝑘𝑟[R2C2] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 𝑘𝑟=2.81E-6 𝑠
−1 
& McCulloch 
38 & PKA + R2𝑏𝑎C → R2𝑏𝑎C2 & 𝑘𝑓[PKA][R2𝑏𝑎C] − 𝑘𝑟[R2𝑏𝑎C2] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.666 𝑠
−1 & McCulloch 
39 & cAMP + R2C2 → R2𝑏C2 & 𝑘𝑓[cAMP][R2C2]− 𝑘𝑟[R2𝑏C2] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=0.762𝑠
−1 & McCulloch 
40 & cAMP + R2𝑏C2 → R2𝑏𝑎C2 & 𝑘𝑓[cAMP][R2𝑏C2]− 𝑘𝑟[R2𝑏𝑎C2] & 𝑘𝑓=1 𝑠
−1 ⋅ 𝜇𝑀−1, 
𝑘𝑟=2.91𝑠
−1 & McCulloch 
 
[table:cAMPrxn2] 
Variations on spatial pattern and model parameters 
LLLL # & Expression & Parameters & Notes 
 
E & 𝐸 =
1−𝑟−𝑟2−𝑠
1−𝑟−𝑟2−𝑠
 & & 
v1 & −𝑏 ∗ 𝑅 & & 
v2 & 𝑚1 ∗ 𝐸 ∗ 𝑟& & 
v3 & 𝑏 ∗ 𝐸 ∗
𝑟
𝑠
∗ 𝑠 & & 
v4 & −(𝑚1 +𝑚2 ∗
𝑠
𝑟






∗ 𝐸 ∗ 𝑟 ∗ 𝑠 & & 
v6 & −𝛽 ∗ 𝑠 & & 
v7 & 𝛽 ∗ 𝐸 ∗ 𝑠 & & 




∗ 𝐸 ∗ 𝑠2 & & 
𝑑𝑟
𝑑𝑡
 & −𝑣𝑟(1 − 𝑠)𝛻𝑟 − 𝑟𝛻𝑠 + 𝑣1 + 𝑣2 + 𝑣3 + 𝑣4 + 𝑣5 & & 
𝑑𝑟2
𝑑𝑡
 & −𝑣𝑟(1 − 𝑠)𝛻𝑟2 − 𝑟2𝛻𝑠 + 𝑣1 + 𝑣2 + 𝑣3 + 𝑣4 + 𝑣5 & & 
𝑑𝑠
𝑑𝑡

















Materials and Methods 
Gene Construction 
For AKAP79-(Ci/Ce)Epac2-camps, AKAP79 (from Dr. John D. Scott) was PCR amplified to 
have HindIII/BamHI digestion sites and (Ci/Ce)Epac2-camps (from Dr. D. Cooper) was PCR 
amplified to have BamHI/EcoRI digestions sites. Both fragments were inserted into pcDNA3 
(Invitrogen) backbone for mammalian expression (cAMP sensor is C terminal to AKAP79). For 
AKAP79-AKAR4, a similar approach was taken where AKAR4 was dropped between 
BamHI/EcoRI. For AC8 (from Dr. D. Cooper), AC8
1-108
, and PDE1C (cDNA from Dr. Yan 
Chen), Gibson Assembly was used to insert the genes into the pcDNA3 mammalian expression 
vector. The shAC8 construct for AC8 knockdown was previously verified and a gift from Dr. 
Jochen Lang. RCaMP was a gift from Dr. Loren Looger. 
Cell Culture 
MIN6 cells (a mouse insulinoma beta cell line) were plated onto sterilized glass coverslips in 35-
mm dishes and grown to 50–90% confluency in DMEM (10% FBS) at 37°C with 5% CO2. Cells 
were transfected using Lipofactamine 2000 (Invitrogen) and grown 20–48 h before imaging. 
Imaging 
Cells were washed twice with Hanks’ balanced salt solution buffer and maintained in the dark at 
room temperature. Cells were imaged on a Zeiss Axiovert 200M microscope with a cooled 
charge-coupled device camera (MicroMAX BFT512, Roper Scientific, Trenton, NJ) controlled 
by METAFLUOR 6.2 software (Universal Imaging, Downingtown, PA). Dual red/cyan emission 
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ratio imaging used a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission 
filters [475DF40 for CFP and 653DF95 for RFP]. Dual yellow/red emission ratio imaging used a 
495DF10 excitation filter, a 515DRLP dichroic mirror, and two emission filters [535DF25 for 
YFP and 653DF95 for RFP]. Dual cyan/yellow emission ratio imaging used a 420DF20 
excitation filter, a 450DRLP dichroic mirror, and two emission filters [475DF40 for CFP and 
535DF25 for YFP]. These filters were alternated by a filter-changer Lambda 10–2(Sutter 
Instruments, Novato, CA). Exposure time was 50–500 ms, and images were taken every 10–30 s. 
Fluorescence images were background-corrected by subtracting the fluorescence intensity of 
background with no cells from the emission intensities of cells expressing fluorescent reporters. 
The ratios of red/cyan, yellow/red, or yellow/cyan emissions were then calculated at different 
time points. The values of all time courses were normalized by dividing each by the average 
basal value before drug addition. Custom Java code and MATLAB scripts were written to 
segment cells, select ROIs, and analyze traces. 
Super-resolution Imaging (STORM) 
For fixed-cell stochastic optical reconstruction microscopy (STORM) imaging, cells were fixed 
with 4% paraformaldehyde (PFA) for 20 min and then washed with 100 mM glycine in Hanks’ 
balanced salt solution (HBSS) to quench the free PFA. Cells were permeabilized and blocked in 
a permeabilization solution with 0.1% Triton X-100, 0.2% bovine serum albumin, 5% goat 
serum, and 0.01% sodium azide in HBSS. The cells were then incubated overnight at 4°C with 
an anti-AC8 antibody (Abcam, ab196686) at a 1:500 dilution or an anti- AKAP150 (Millipore 
Sigma 07-210) antibody at a 1:1000 dilution, followed by 1 to 2 hours with goat anti-rabbit 
Alexa 647–conjugated antibodies at 1:1000 dilution. The cells were then post-fixed again in 4% 
PFA, quenched with 100 mM glycine in HBSS, and washed with HBSS to prepare for imaging. 
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Immediately before imaging, the medium was changed to STORM-compatible buffer [50 mM 
tris-HCl (pH 8.0), 10 mM NaCl, and 10% glucose) with glucose oxidase (560 g/ml), catalase 
(170 g/ml), and mercapto-ethylamide (7.7 mg/ml). STORM images were obtained using a 
Nikon Ti total internal reflection fluorescence (TIRF) microscope with N-STORM, an Andor 
IXON3 Ultra DU897 EMCCD, and a 100× oil immersion TIRF objective. Photoactivation was 
driven by a Coherent 405-nm laser, while excitation was driven with a Coherent 647-nm laser. 
Illumination was done in a “near-TIRF” format, in which the TIRF angle was adjusted so that 
molecules in the nucleus were illuminated. All image analysis and image reconstruction were 
performed using both Nikon Elements analysis software and custom-written MATLAB scripts. 
Cluster measurements were performed using Ripley-K analysis and custom mean-shift code for 
segmentation. 
Proximity Ligation Assay 
Antibodies for AC8 and AKAP150, mentioned in STORM section, were buffer exchanged into 
DPBS and conjugated with MINUS or PLUS oligos, following the Sigma DuoLink in situ 
Probemaker kits. PLA experiments were performed using the Duolink® in situ red kit for 
proximity ligation assays according to the provided protocol. The only protocol modification was 
to extend the amplification time by 50 min. Briefly, cells were fixed and permeabilized as in the 
STORM experiments before incubation with PLUS and MINUS oligo-conjugated primary 
antibodies for 30 min at 37°C each with washes after each step. Ligation of the nucleotides and 
amplification of the strand occurred sequentially by incubating cells with first ligase then 
polymerase and detection solution. PLA experiments with AKAP95 antibodies from different 
species were used as positive controls in HEK293T cells, and experiments with just one oligo-
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labeled primary antibody or the other were our negative control. Images were acquired on a 
Nikon Ti Eclipse epifluorescence scope with z-control. A cross section of the nucleus (3.6-5 μm) 
was acquired and the number of dots per cell was counted using the nucleus as reference.   
Computational Modeling 
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Growing evidence suggests many essential intracellular signaling events are compartmentalized 
within kinetically-distinct microdomains in cells. However, current tools used to dissect the 
spatiotemporal dynamics within these domains typically rely on fusion proteins and 
overexpression of critical regulatory elements. Here we present a novel class of FRET-based 
biosensors FluoSTEPs (Fluorescent Sensors Targeted to Endogenous Proteins) to study 
compartmentalized signaling dynamics in situ using a split biosensor approach. By utilizing a 
self-complementing split GFP, CRISPR-mediated knock-in, and FRET imaging, our FluoSTEPs 
can simultaneously highlight endogenous microdomains and report domain-specific, real-time 
signaling events in live cells. We demonstrate the application of FluoSTEPs by probing cAMP 
signaling within clathrin microdomains and PKA activity at organization centers of PKA 
regulatory subunits. FluoSTEPs represent a novel toolset for studying spatiotemporal regulation 
within endogenous signaling architectures.  
Introduction 
Compartmentalization of intracellular signals by macromolecular complexes can reshape the 
kinetics of cellular processes and provide diversity in signaling pathways while simultaneously 
preserving specificity. Our understanding of such microdomain architecture of signaling 
networks has greatly benefited from the design of optically-based, genetically encoded 
biosensors (Greenwald et al. 2018). By attaching such sensors to organizational proteins of 
interest (POI) and introducing these fusions to living cells, researchers can monitor 
compartmentalized signals in real time (Tenner et al. 2016). 
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Despite the utility of such biosensors, this fusion strategy has drawbacks primarily stemming 
from unintended effects from the concomitant expression of the POI. Overexpression of enzymes 
or scaffolds can disrupt native signaling pathways by causing mislocalization, artificially 
enhancing/weakening certain fluxes, and/or affecting the stoichiometry of macromolecular 
interactions. This can perhaps best be illustrated in the previous chapter where overexpression of 
the PKA-anchoring scaffold altered signaling dynamics within the scaffold’s microcompartment. 
Additionally, some biosensor architectures themselves include enzymatic components known to 
affect global signaling within the cell. For example, the Raichu-Ras sensor for measuring activity 
of the G-protein Ras contains active Ras within a conformational switch; however, 
overexpression of Ras is a hallmark of several cancers with associated, downstream signaling 
effects (Mochizuki et al. 2001; Fernandez-Medarde et al. 2011). Strategies have attempted to 
address overexpression concerns, for example, by utilizing nanobodies for highlighting 
endogenous, active receptors, or intrabodies to recruit biosensors to endogenous compartments 
(Irannejad et al. 2013; Perez-Alvarez et al. 2019). However, perturbations in trafficking and 
signaling due to nanobody binding, as well as issues of compartment specificity are still ever-
present. Ideally, an approach that combined the strength of quantitative biosensing, specificity of 
genetic fusions, and minimally-invasive probing of endogenous POIs, would be valuable for 
dissecting compartmentalized signaling within living cells.      
Here we present a versatile platform for probing endogenous microdomains termed FluoSTEPs: 
Fluorescent Sensors Targeted to Endogenous Proteins. By utilizing a self-complementing split 
GFP as a FRET donor, we designed a suite of ratiometric sensors that can be recruited and 
reconstituted at tagged POIs (Cabantous et al. 2005; Pedelacq et al. 2006). Generation of the 
functional biosensors only at a POI ensures compartment specificity, and the small size of GFP11 
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facilitates endogenous mobilization. Efficient knock-in of GFP11 at a specific genomic locus via 
CRISPR-mediated homology-directed repair (Kamiyama et al. 2016) precludes overexpression 
of the POI as well as bypasses the need for knocking in an entire FRET-based sensor. We 
showcase FluoSTEPs by deploying the new sensors to uncover mechanisms governing sustained 
cyclic adenosine monophosphate (cAMP) dynamics at clathrin and differential Protein Kinase A 
(PKA) activity at the regulatory subunit isoform RIα.  
Results and Discussion  
FluoSTEP-AKAR is reconstituted and functional at microdomains of interest 
In order to evaluate the design of the FluoSTEP strategy, we first sought to build a prototype 
sensor. We chose the well-characterized, FRET-based biosensor for Protein Kinase A (PKA) 
activity, AKAR4 (Depry et al. 2011), as a template for our initial design and testing. In AKAR4, 
PKA-specific phosphorylation on a substrate domain causes its binding with the phospho-amino 
acid binding domain FHA1 fused to the substrate domain, which results in a conformational 
change between the CFP (Cerulean) donor and YFP (cpVenus) acceptor, leading to an increase 
in FRET. For a FluoSTEP version of the AKAR4 reporter, we wished to design a logic-gated 
sensor for PKA activity in which most of the sensor exists in a nonfunctional state and would 
only become functional at a POI. Although an intrabody-based approach could be utilized for 
effective sensor recruitment, it would still be sensitive to overexpression due to the sensor 
existing only in a functional state. In order to install the PKA sensor with such control logic, we 
adopted a split super-folder GFP (sfGFP) as a FRET donor and an RFP as a FRET acceptor 




 beta strands (GFP1-10 and 





and GFP fluorescence is reconstituted (Pedelacq et al. 2006). We hypothesized that the small 
GFP11 fragment (16 amino acids) could easily be fused to a POI and when the GFP1-10 fragment 
is present, reconstitution of a donor fluorophore occurs and gives rise to a functional FRET-
based sensor only at the POI (Figure 3.1a). This domain-specific logic control could then 
promote ratiometric imaging for measuring compartmentalized PKA activity at endogenous 





Figure 3.1 General design for the FluoSTEP platform for sensing PKA activity. (A) Two constructs comprising 
the FluoSTEP-AKAR design where the POI is tagged with the short GFP11 tag and the AKAR sensor is made from 
GFP1-10, RFP, and the conformational switch (PKA substrate and phosphor-amino acid binding domain FHA1). The 
phosphorylation site on the PKA substrate domain is highlighted in red. (B) FluoSTEPs work by reconstituting the 
donor FP, in this case the split GFP, at a POI. Reconstitution of the GFP gives rise a functional FRET-based sensor 
so that localized kinase and phosphatase activities are translated into changes in the FRET between the donor GFP 
and an RFP acceptor.     
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To test this design, we took AKAR4 and exchanged Cerulean for GFP1-10 and cpVenus for 
mRuby2 to make a complementation-dependent green-red (GR) FRET probe (G1-10-R-
FluoSTEP-AKAR) (Lam et al. 2012). We also made a second version in parallel by swapping 
the order of GFP1-10 and mRuby2 (R-G1-10-FluoSTEP-AKAR) due to the difference in termini 
locations of GFP1-10 and in an attempt to preserve the original, relative orientations of AKAR4’s 
fluorescence transition dipoles’ moments (Lakowicz 2006). In the presence of transiently 
transfected GFP11-fused actin (actin-GFP11) in HEK293T cells, GFP fluorescence was 
spontaneously reconstituted for both versions at actin (Figure 3.2a). However, only the second 
sensor (R-G1-10-FluoSTEP-AKAR) produced a robust, inducible PKA response after the addition 
of forskolin (fsk, 50μM) and IBMX (100μM) (8.3% ± 0.4% change in FRET ratio, n=12), as 
measured by the change in the FRET ratio (RFP FRET / GFP direct) (Figure 3.2b,c). The G1-10-
R-FluoSTEP-AKAR sensor was noisy and did not produce a clean, monotonic PKA-induced 
response (n=12), so we continued to characterize the R-G1-10-FluoSTEP-AKAR sensor, termed 
FluoSTEP-AKAR. As a negative control, the phosphorylated threonine in the PKA substrate 
domain was mutated to an alanine, rendering the FluoSTEP-AKAR in a perpetual “OFF” state 
and unresponsive to stimulation (Figure 3.3a). To test recruitment and functioning at another 
POI, we co-expressed clathrin-tagged GFP11 and FluoSTEP-AKAR and observed GFP 
reconstitution (Figure 3.3b). Sensor functionality was again tested with fsk/IBMX treatment, and 
then PKA specificity and sensor reversibility was also checked by acute addition of H89 (10μM), 
a potent PKA inhibitor, post-fsk/IBMX stimulation. We observed a robust PKA response to 
fsk/IBMX (10.5% ± 1.6% increase), followed by a return to baseline after H89, as measured by 





















Figure 3.2 Testing of two versions of FluoSTEP-AKAR where the split GFP and mRuby2 are on different 
termini. (A) Image of HEK293T cells with R-G1-10-FluoSTEP-AKAR and actin-GFP11 co-expressed. GFP channel 
is shown, reconstitution is observed. (scale 10μm) (B) Schematic depicting G1-10-R-FluoSTEP-AKAR with the split 
GFP on the N terminus and mRuby2 at the C terminus. Co-expression with actin-GFP11 reconstitutes the GFP but 
fails to yield a clean, monotonic response to fsk (50uM, adenylyl cyclase activator) and IBMX (100uM, 
phosphodiesterase inhibitor) added at 0min (n=12). (C) Schematic depicting R-G1-10-FluoSTEP-AKAR with the split 
GFP on the C terminus and mRuby2 at the N terminus. Co-expression with actin-GFP11 reconstitutes the GFP yields 
a response to fsk (50uM) and IBMX (100uM) added at 0min (8.3% ± 0.4%, n=12). FRET (R/G) is the FRET ratio 
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Figure 3.3 FluoSTEP-AKAR is PKA specific and reversible. (A) FluoSTEP-AKAR with the T/A 
phosphorylation mutation at the PKA substrate domain (gray trace) is unresponsive to PKA stimulation, compared 
to the wild type FluoSTEP-AKAR (green trace). (B) FluoSTEP-AKAR is functional at co-expressed GFP11-tagged 
clathrin (inset, HEK293T, GFP channel, scale 10um). Fsk/IBMX elicited a 10.5% ± 1.6% increase in FRET, and 
H89 (10uM) addition to inhibit PKA returned the trace to baseline, highlighting the reversibility of the sensor (n=6).  
 
 
We next attempted to increase the dynamic range of the FluoSTEP-AKAR probe in order to 
improve the signal-to-noise ratio (SNR). We first tried exchanging the split donor for a brighter, 
split version of mNeonGreen with an orthogonal FP11 tag attached to clathrin (Feng et al. 2017); 
however, we observed a smaller dynamic range (4.0% ± 0.3%, n=9) (Figure 3.4a), potentially 
due to the slightly more red-shifted spectra of mNeonGreen and thus an enhanced overlap of 
both fluorescent proteins’ (FPs) emission spectra and a dampened change in the FRET ratio 
(Lam et al. 2012). GR-FRET sensors can sometimes possess smaller dynamic ranges compared 
to equivalent yellow-red (YR) or cyan-yellow (CY) variants (Depry et al. 2011; Ni et al. 2011; 
Lam et al. 2012) and so we next exchanged the donor GFP1-10 for two color variants derived 
74 
 
from single-residue mutations to split sfGFP: yellow YFP1-10 and cyan CFP1-10 (Kamiyama et al. 
2016). We created R-Y1-10-FluoSTEP-AKAR with the YFP1-10 as donor and mRuby2 as 
acceptor; co-expressed with actin-GFP11, this construct yielded a small response (~4%, n=3) 
after fsk/IBMX addition, but suffered from drift (Figure 3.5a). For testing CFP1-10, we instead 
used the yellow cpVenus from AKAR4 as the acceptor and CFP1-10 as the donor to create a Y-C1-
10-FluoSTEP-AKAR, however, the sensor yielded a noisy response with a low dynamic range 
(~3%, n=3) after fsk/IBMX treatment and co-expressed with actin-GFP11 (Figure 3.5b). This is 
most likely due to the low inherent brightness of the reconstituted CFP. Future work with this 
construct could focus on improving the photophysical properties of the reconstituted CFP, in 
addition to the dynamic range, in order to expand the color palette of FluoSTEPs and promote 
multiplexed imaging. Lastly, we tried replacing mRuby2 with mRuby3 or mScarlet-I as an RFP 
acceptor for GFP1-10 with co-expressed actin-GFP11 (Bajar et al. 2016; Bindels et al. 2017). 
While mRuby3 failed produce a discernable response (n=7) (Figure 3.6a), mScarlet-I did yield a 
sensor with an improved range (18.4% ± 0.4%, n=27), representing an approximate 2-fold 
increase over the mRuby2 version (Figure 3.6b). However, we observed that the sensor exhibited 
much higher direct excitation of mScarlet-I when exciting the split GFP. Further work will need 
to be done to validate this sensor’s utility under different imaging conditions (for example by 











Figure 3.4 mNeonGreen-based FluoSTEP-AKAR 
does not improve the dynamic range of the sensor. (A) 
Schematic depicting mNG1-10 replacing GFP1-10 in 
FluoSTEP-AKAR.  Fsk/IBMX triggered a modest 4.0% 

















Figure 3.5 FluoSTEP-AKAR versions with split YFP or split CFP as donors do not work well. (A) Schematic 
of the Y-C1-10-FluoSTEP-AKAR sensor. Fsk/IBMX failed to elicit a measurable response in the presence of actin-
GFP11, further optimization will be needed. (n=3) (B) Schematic of the R-Y1-10-FluoSTEP-AKAR sensor. 
Fsk/IBMX did trigger an inflection in the presence of actin-GFP11, but the baseline is drifting, preventing the 
sensor’s utility in its current state. (n=3) 
 
A B Y-C1-10-FluoSTEP-AKAR R-Y1-10-FluoSTEP-AKAR 
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Figure 3.6 Optimizing the RFP acceptor for FluoSTEP-AKAR. (A) Schematic depicting mRuby3 in the 
FluoSTEP-AKAR. The FRET ratio displays drifting and fsk/IBMX fails to elicit a discernable response (. (B) 
Schematic depicting mScarlet-I in the FluoSTEP-AKAR Utilizing mScarlet-I does boost the dynamic range of the 
fsk/IBMX-induced response (18.4% ± 0.4%, n=27) (light green trace is mScarlet-I, dark green is and additional 
mRuby2 experiment for comparison), however, direct excitation of the RFP is extensive when exciting the split 
GFP, so further characterization is warranted. Actin-GFP11 is co-expressed in these comparisons.  
 
 
Due to the small size of the GFP11 tag (16 amino acids) and the demonstration that an array of 
the tag could be harnessed to linearly boost the brightness of the fluorescent tag (Kamiyama et 
al. 2016), we hypothesized that a similar strategy could be utilized to recruit multiple copies of 
the FluoSTEP sensor and amplify the high-FRET state through increased intermolecular FRET 
(Klarenbeek et al. 2015). First, we co-expressed actin fused with an array of seven copies of 
GFP11 (actin-GFP11x7) and FluoSTEP-AKAR in HeLa cells in order to see if the actin 
organization was affected by the interaction of many sensors. Recruitment of multiple sensors 
didn’t grossly alter the actin architecture (Figure 3.7a). To test the sensor’s functionality, we 
stimulated with fsk/IBMX. Although the brightness in the GFP channel was only 1.8x higher 
between co-expressed actin-GFP11x7 and actin-GFP11x1 (assessed in HeLa, n=19, 27) (Figure 
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3.7a), we observed an enhancement of the dynamic range by approximately 2x, indicating that an 










   
FluoSTEP design can be generalized for multiple biosensors 
Many FRET-based biosensors are generated based on a modular design where a signal-specific 
conformational switch is sandwiched between a FRET pair of FPs. This architecture facilitates 
the straightforward assembly of sensors for a suite of different biological activities by simply 
swapping out the signal-specific switch domain (Zhang et al. 2007). So next we sought to take 
advantage of this generalizable design and expand the arsenal of FluoSTEP sensors. In addition 
to PKA, many kinases are organized in macromolecular complexes or subcellularly-targeted in 
A 
B 
Figure 3.7 An array of GFP11 can be used to enhance 
the dynamic range of FluoSTEP-AKAR. (A) HeLa cell 
expressing actin-GFP11x7 and FluoSTEP-AKAR. The 
recruitment of multiple sensors does not alter actin 
localization. (GFP channel, scale 10um). (B) Relative 
reconstituted GFP intensity (with FluoSTEP-AKAR) 
indicates GFP11x7 is on average 1.8x brighter than 
GFP11x1 cells (HEK293T, p<0.05, n=19, 27). (C) In HeLa 
cells, the dynamic range of FluoSTEP-AKAR was 
boosted in the presence of actin-GFP11x7 vs. actin-
GFP11x1 (7.9% ± 1.2% vs. 3.9% ± 0.8%, an increase of 2-




order to tune signaling kinetics and target specificity (Wang et al. 2011). For example, 
compartmentalization of Akt kinase and JNK, two kinases important within cellular survival and 
stress pathways, has been uncovered using FRET-based biosensors (Gao et al. 2008; Zeke et al. 
2016; Zhou et al. 2015). By simply swapping out the PKA substrate domain for the 
phosphorylation target domains of Akt kinase and JNK, we created FluoSTEP versions of the 
previously published AktAR (Akt Activity Reporter) and JNKAR (JNK Activity Reporter), 
respectively, and tested these in the presence of actin-GFP11x1. Upon activation of Akt via PDGF 
(50ng/mL), we observed a robust FRET ratio change with FluoSTEP-AktAR (7.9% ± 1.6%, 
n=21) (Figure 3.8a). Similarly, stimulation of JNK activity with anisomycin (5uM) yielded a 
delayed, stress-induced response in the FRET ratio from FluoSTEP-JNKAR (4.4% ± 1.7%, n=7) 
(Figure 3.8b). Other FRET-based kinase sensors utilize different sets of substrate domain and 
phospho-amino acid binding domain for the conformational switch. A FluoSTEP-EKAR for the 
Erk kinase (Erk Kinase Activity Reporter), a kinase essential in cell growth and differentiation, 
was also created by replacing the substrate domain (Erk substrate) and the phospho-amino acid 
binding domain (WW domain), as well as the addition of an extended linker (EV) in-between 
(Komatsu et al. 2011). A robust response was observed upon EGF (100ng/mL) addition, co-
expressed with actin-GFP11x1 (4.0% ± 0.4%, n=42) (Figure 3.8c). As negative controls, the 
phosphorylation mutant versions of these kinase sensors were also synthesized and were 




FluoSTEP-AktAR FluoSTEP-JNKAR FluoSTEP-EKAR A B C 
 
 
Figure 3.8 Kinase FluoSTEPs for Akt kinase, JNK, and Erk kinase. (A) Schematic of FluoSTEP-AktAR. Blue 
trace is FluoSTEP-AktAR, gray is phosph. mutant. FluoSTEP-AktAR responds with co-expressed actin-GFP11 upon 
PDGF (50ng/mL) stimulation (7.9% ± 1.6%, n=21, 3T3 cells, scale 10um). (B) Schematic of FluoSTEP-JNKAR. 
Orange trace is FluoSTEP-JNKAR, gray is phosph. mutant. FluoSTEP-JNKAR responds with co-expressed actin-
GFP11 upon anisomycin (5uM) stimulation (4.4% ± 1.7%, n=7, HeLa cells, scale 10um). (C) Schematic of 
FluoSTEP-EKAR. Red trace is FluoSTEP-EKAR, gray is phosph. mutant. FluoSTEP-EKAR responds with co-
expressed actin-GFP11 upon EGF (100ng/mL) stimulation (4.0% ± 0.4%, n=42, HEK293T cells, scale 10um). 
 
 
As mentioned previously, some FRET-based biosensors incorporate enzymatic components 
within their design architecture. In many contexts, this is unfavorable due to unwanted effects 
from overexpression. Thus, we hypothesize FluoSTEPs could help untangle this dependence by 
uncoupling the expression of the enzymatic component from the rest of the sensor and produce 
functional sensors only when both parts are present. As a prototype, we turned our attention to 
the RhoA-DORA sensor which measures the activation of RhoA, a small GTPase important in 
cytoskeletal regulation, by transducing a binding event between GTP-bound RhoA and the 
interactor domain cpPKN into an increase in FRET (van Unen et al. 2015). We created our own 





Figure 3.9 FluoSTEP for RhoA activity. (A) Schematic 
of FluoSTEP-RhoA-DORA. Purple trace is FluoSTEP-
RhoA-DORA, gray is inactivated mutant. FluoSTEP-
RhoA-DORA reconstitutes and responds to histamine 
(100uM) stimulation (9.0% ± 1.5%, n=20, HeLa cells, 
scale 10um). 
with the small GFP11 and the remainder of the sensor (cpPKN-mRuby2-EV-GFP1-10) 
incorporated GFP1-10, thus splitting the sensor into two separate parts (Figure 3.9a). By 
expressing both parts, we successfully reconstituted the donor GFP. Upon stimulating RhoA 
activity with histamine (dose), the activated FluoSTEP-RhoA-DORA sensor responded robustly 
(9.0% ± 1.5%, n=20), compared to an inactivated mutant version (Figure 3.9a). Interestingly, the 
FluoSTEP architecture for this sensor reversed the activity-induced FRET change (from a 
positive to a negative change in the FRET ratio), likely due to differences in dipole orientation 
between the original and our FluoSTEP version, and so we inversed the FRET ratio and plotted 
the GFP direct channel divided by the RFP FRET channel in order to observe a positive trace. 
The design for FluoSTEP-RhoA-DORA could potentially be adapted for endogenous tagging of 










Finally, we sought to extend the FluoSTEP framework to second messenger detection. Cyclic 
adenosine monophosphate (cAMP), the upstream regulator of PKA, is found to exert its diverse 
regulatory roles through compartmentalization (Calebiro et al. 2014). Most cAMP sensors work 
by translating a cAMP-binding event into a conformational change of a single domain (Violin et 
al. 2007; Klarenbeek et al. 2015), which modulates FRET between flanking FPs. We tested two 
different cAMP-binding switches between mRuby2 and GFP1-10 derived from the cAMP-binding 




), and found only the longer switch 
produced a response (5.9% ± 0.6%, n=10) upon fsk/IBMX addition and co-expressed actin-
GFP11 (Violin et al. 2007; Nikolaev et al. 2004) (Figure 3.10a). The FluoSTEP version 
(FluoSTEP-ICUE: Indicator of cAMP Using Epac) retains its negative FRET reporter behavior 
from the previous cAMP sensor (binding of cAMP lead to a decrease in the FRET ratio and thus 
we plotted GFP direct over RFP FRET for a positive trace) and was utilized in the following 
experiments. In addition, we also demonstrated that amplification of the dynamic range could be 
















Figure 3.10 A FluoSTEP for cAMP. (A) Schematic of a generalized FluoSTEP for cAMP with single-chain 
conformational switch derived from the Epac family. Light orange trace is using Epac2B(285-443) and dark orange 
is using Epac1(149-881). Robust response from the Epac1-based FluoSTEP was observed in the presence of co-
expressed actin-GFP11 (5.9% ± 0.6%, n=10, HEK293T). (B) Amplification of the dynamic range was observed when 
using an array of seven repeats of the GFP11 tag on actin for the FluoSTEP-ICUE probe, compared to a single copy 
(GFP11x1) (10.0% ± 0.6% vs. 5.8% ± 0.6%; 1.7x improvement, n=17,10, HEK293T). 
 
 
Endogenous signaling compartments are accessible by FluoSTEPs 
In order to test the compartment-specific FluoSTEP sensors in an endogenous context, we sought 
to knock-in GFP11 at specific genomic loci in HEK293T cells. Due to the small size of GFP11, 
knock-in via CRISPR and HDR with a single-stranded oligonucleotide donor is efficient and 
versatile and can theoretically be extended to multiple genomic loci of interest (Kamiyama et al. 
2016; Mali et al. 2013). In order to test the FluoSTEP platform with a POI at the endogenous 
level, we knocked-in GFP11 into the SEC61B locus which codes for one of the subunits in the 
Sec61 protein translocon at the ER on the cytosolic face (Wiertz et al. 1996). By expressing the 




monitored the FRET ratio and noticed a positive drift, possibly due to donor GFP photobleaching 
and/or photochromic behavior of mRuby2 (Bindels et al. 2017; Botman et al. 2019). However, 
fsk/IBMX addition triggered an inflection in the trace, indicating a response, albeit weak, which 
was reversed upon later H89 treatment (n=28)  (Figure 3.11b). FluoSTEP-ICUE was also tested 
in this context and yielded a robust response to fsk/IBMX addition (Figure 3.11c). Taken 
together, this suggests that the FluoSTEP platform can be used for monitoring signaling 




Figure 3.11 FluoSTEPs can monitor signaling at the endogenous Sec61 translocon at the ER. (A) Knock-in and 
reconstitution of GFP at Sec61B in HEK293T (scale 20um). (B) FluoSTEP-AKAR can monitor PKA signaling at 
Sec61B, as indicated by the inflection but suffers from drift, however, it maintains its reversibility (n=28). (C) 







Transmembrane adenylyl cyclases regulate sustained cAMP production at clathrin 
Clathrin, a scaffold protein important in the formation and endocytosis/exocytosis of vesicles, 
modulates cAMP signaling by promoting internalization of G-coupled receptors and mediating 
receptor recycling (Kaksonen et al. 2018). It has also been suggested that GPCR internalization 
arbitrates a distinct secondary phase of cAMP signaling from endosomes (Calebiro et al. 2010), 
and so we wished to take a closer look at compartmentalized cAMP dynamics at the clathrin 
microdomain. We knocked-in the GFP11 tag into the gene that encodes for the clathrin light chain 
A (CLTA) in HEK293T cells and found that the donor GFP was reconstituted when we 
expressed FluoSTEP-AKAR. Distinct clathrin-coated pits were observed, indicating correct 
localization of FluoSTEP-AKAR (Figure 3.12a). By treating cells with fsk/IBMX, we reliably 
detected a rapid increase in PKA activity within the clathrin microdomain (12.5% ± 0.7%, n=33) 
(Figure 3.12b). Sensor reversibility was checked with subsequent addition of H89 and we 
observed the FRET return to baseline. To monitor microdomain-specific cAMP, we utilized the 
FluoSTEP-ICUE sensor. Treatment with fsk/IBMX successfully triggered a rapid FRET change 













Figure 3.12 FluoSTEPs can monitor signaling at endogenous clathrin. (A) Knock-in and reconstitution of GFP 
at clathrin in HEK293T (scale 20um). Clathrin-coated pits are visible, see inset. (B) FluoSTEP-AKAR can monitor 
PKA signaling at clathrin as indicated by a robust response after fsk/IBMX, and maintains reversibility (12.5% ± 
0.7%, n=33). (C) FluoSTEP-ICUE can monitor cAMP signaling at clathrin (n=12). 
 
 
To probe the clathrin-specific cAMP dynamics under physiologically-relevant conditions, we 
expressed FluoSTEP-ICUE and stimulated the CLTA-FP11 cells with isoproterenol (iso, 10uM), 
a potent beta adrenergic receptor agonist, eventually followed by a maximizing dose of 
fsk/IBMX for normalization. Isoproterenol induced a robust, sustained response (approx. 30% of 
max, approx. SAM20 = 0.9, n=15; SAM20 = (R20-R0) / (Rmax-R0) where R20 is ratio at 20min 
post stimulation, Rmax is maximum ratio occurring within 20min, R0 is ratio at time=0min) 
measured by whole-cell fluorescence, illustrating the sensitivity of FluoSTEPs under 
submaximal stimulation conditions (Figure 3.13a). We also detected internalization of clathrin-
coated pits, demonstrating that the presence of FluoSTEP-ICUE does not block this process 








dynamics with bulk cAMP signals, we expressed a CY-FRET cAMP probe with the same Epac-
based switch domain (Violin et al. 2007) either untargeted or targeted to the general plasma 
membrane (PM) via the lyn kinase palmitoylation sequence (lyn-ICUE). Upon isoproterenol 
stimulation, the cAMP signal for both untargeted and PM-targeted ICUE rose sharply (approx. 
50% of max, SAM20 = 0.45, n=25,28) before decreasing and setting at a sub-maximum steady-
state (Figure 3.13a). This indicates that iso-stimulated cAMP in the cytoplasm and general PM is 
transient, supporting previous reports of cAMP clearance due to the desensitization of canonical 
beta adrenergic receptor signaling (Violin et al. 2007). To verify the sustained cAMP response at 
clathrin versus the transient dynamics at the PM wasn’t due to an artifact of the FluoSTEP probe, 
we reconstituted FluoSTEP-ICUE at the PM by co-expressing FP11 tagged to a lyn-fused protein 







Figure 3.13 cAMP at endogenous clathrin is sustained upon beta adrenergic stimulation. (A) Traces showing 
cAMP generation upon iso stimulation, normalized to a maximizing dose of fsk/IBMX. Red trace is FluoSTEP-
ICUE, green is untargeted ICUE, blue is plasma membrane-targeted ICUE, and purple is the FluoSTEP control at 
the PM. (B) SAM20 (ratio measurement of sustainability) for the traces in A. FluoSTEP-ICUE displays a more 
sustained cAMP response at endogenous clathrin, compared to the other targeted sensors. (n=15, 25, 28, 8) (p<0.05) 
(C) Iso stimulation triggers internalization of clathrin-coated pits, indicating that the FluoSTEP does not disrupt the 
physiology (scale 10um).  
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We hypothesized that sustained cAMP signaling at the clathrin microdomain might be due to 
continuous signaling via the beta adrenergic receptor, and so we treated cells 35min post-
stimulation with an acute dose of 2-propranolol, a beta adrenergic receptor antagonist (10uM). 
The general PM cAMP decreased and approached a pre-iso stimulated baseline (n=18), however, 
for the clathrin microdomain-specific signal, cAMP dynamics were unaffected (n=13), indicating 
that the sustained cAMP response in the clathrin microdomain is not dependent on the active 
receptor (Figure 3.14a). cAMP signaling can be compartmentalized by the organization of 
adenylyl cyclases (ACs) and phosphodiesterases (PDEs) within the cell (Calebiro et al. 2014). To 
test the regulatory role of these enzymes, we acutely inhibited either PDEs with IBMX (100uM) 
or transmembrane ACs (tmACs) with 2’,3’-dideoxyadenosine (ddAdo, 100uM) post-iso 
stimulation. Interestingly, we found that PDE inhibition potentiated cAMP at the general PM but 
had little effect at clathrin (n=23,21). On the other hand, tmAC inhibition sharply reduced cAMP 
levels back to a pre-stimulation baseline at clathrin but only had minimal effect on the general 
PM cAMP signal (Figure 3.14b) (n=25,25). Taken together, this suggests that active tmACs, in 
the absence of the active receptor, are responsible for the sustained, compartmentalized cAMP 
dynamics at clathrin while a shifted balance towards high PDE activity is responsible for the 
















Figure 3.14 tmACs are responsible for the sustained cAMP at endogenous clathrin. (A) Traces comparing 
ICUE at the PM (lyn target, blue trace) vs. FluoSTEP-ICUE (shown here as the red trace) upon propranolol 
treatment. The clathrin cAMP microdomain is insensitive to the beta blocker. (B) FluoSTEP-ICUE also 
demonstrates that the clathrin cAMP microdomain is insensitive to general phosphodiesterase inhibition. (C) tmAC 
inhibition by ddAdo decreases the clathrin-specific cAMP microdomain signal.  
 
 
PKA regulatory subunit RIα spatially modulates cAMP and PKA activity within cells 
PKA signaling is compartmentalized via interactions between PKA’s regulatory subunits and 
various scaffold proteins, such as A-Kinase Anchoring Proteins (AKAPs) (Greenwald et al. 
2012). Although cooperation between the regulatory subunit RII isoforms and AKAPs have been 
extensively studied (Wong et al. 2004), much less is understood about the compartmentalizing 
role of RI isoforms. Recently it was demonstrated that the RIα isoform organizes into punctate 
structures in the cytoplasm, which possessed sensitivity to PKA activity (Day et al. 2011), and so 
we wished to deploy FluoSTEPs to study this localized signaling domain at the endogenous 
context. To start, we successfully knocked-in GFP11x1 into the RIα locus in HEK293T, 
transiently transfected GFP1-10, and observed endogenous RIα, both in puncta and diffuse, 
distributed throughout the cytoplasm (Figure 3.15a). In order to probe RIα-localized PKA 
activity, we transfected FluoSTEP-AKAR in the RIα-GFP11x1 stable cells and stimulated AC 
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activity with fsk. Interestingly, we found differential PKA sensitivity between punctate and 
diffusively-distributed RIα. While PKA activity modulation was observed in the diffuse RIα, 
PKA activity at the punctate structures did not respond to fsk treatment (Figure 3.15b). We then 
looked upstream at stimulated cAMP production in the two compartments with FluoSTEP-ICUE 
and observed a similar difference (Figure 3.15c). Taken together, this suggests that localized 
cAMP/PKA signaling at these RIα puncta is spatiotemporally regulated and further work needs 




Figure 3.15 PKA regulatory subunit R1α spatially modulates cAMP and PKA.  (A) Image of endogenous 
R1alpha in HEK293T (scale 10um). R1alpha exists in both puncta and diffuse regions about the cell. (B) 
Differential PKA activity at the R1alpha puncta and diffuse locations is seen in fsk stimulated conditions (dark green 
puncta, light green diffuse) (n=8,8). (C) The same insensitivity is seen with fsk-triggered cAMP production (light 








Here we present FluoSTEP, an adaptable biosensor framework for monitoring 
compartmentalized signaling at endogenous cellular locations, and deploy it to study cAMP/PKA 
signaling microdomains. Complementation and functional reconstitution of the sensors at 
endogenously tagged proteins imparts a control logic, and thus domain specificity, while the 
ratiometric readout allows quantitative comparisons of localized signaling. Despite the 
demonstrated advantages of the platform, potential obstacles such as the low dynamic range of 
the sensors and the dependence on the endogenous expression must be considered. While 
enhanced FP reconstitution at endogenous POIs and an amplified dynamic range using an array 
of the GFP11 tag has been demonstrated, future development and optimization of FluoSTEPs will 
include linkers and additional FP screening. Furthermore, by extending the FluoSTEPS to utilize 
orthogonal, multicolored FP variants, several sensors may be multiplexed and simultaneously 
report differential compartmentalized signaling in the same cell. FluoSTEPs offers researchers a 
minimally perturbative method of observing microdomain-specific signaling at an endogenous 









Materials and Methods 
Biosensor Construction 
All assembly of constructs was performed using Gibson Assembly (NEB 2x High Fidelity 
Master Mix). To make FluoSTEP-AKAR, the PKA switch domain from AKAR4 and mRuby2 
were PCR amplified and inserted into a pcDNA3.1+ (Invitrogen) vector containing GFP1-10. 
Color variants of FluoSTEP-AKAR to optimize the dynamic range were made similarly by PCR 
amplification of the FP to swap in and the remainder of the FluoSTEP-AKAR minus FP to swap 
out. Assembly of other FluoSTEP versions was made by simply swapping out the switch domain 
between GFP1-10 and mRuby2 from FluoSTEP-AKAR for switch domains from CKAR to make 
FluoSTEP-CKAR, AktAR to make FluoSTEP-AktAR, and EKAR2.3 to make FluoSTEP-
EKAR, via PCR amplification and Gibson Assembly. FluoSTEP-RhoA-DORA sensor parts were 
assembled by PCR amplification of RhoA with extension PCR to add GFP11 and cpPKN, 
mRuby2, and GFP1-10 for the other parts. 
Cell Culture and Transfection 
HeLa and HEK293T cells were cultured in Dulbecco modified Eagle medium (DMEM; Gibco) 
containing 1 g/L glucose and supplemented with 10% (v/v) fetal bovine serum (FBS, Sigma) and 
1% (v/v) penicillin-streptomycin (Pen-Strep, Sigma-Aldrich). NIH3T3 cells were cultured in 
DMEM (Gibco) containing 1 g/L glucose and supplemented with 10% (v/v) fetal calf serum 
(FCS) and 1% (v/v) Pen-Strep (Sigma-Aldrich). All cells were maintained in a humidified 
incubator at 37°C with a 5% CO2 atmosphere. Prior to transfection, cells were plated onto sterile 
35-mm glass-bottomed dishes and grown to 50–70% confluence. Cells were then transfected 
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using Lipofectamine 2000 (Invitrogen) or PolyJet (SignaGen Laboratories) and grown an 
additional 24 h (HeLa, HEK293T) before imaging. NIH3T3 cells were changed to serum-free 
DMEM immediately prior to transfection and serum-starved for 24 h before imaging.  
CRISPR-mediated knock-in for stable GFP11 cell lines 
For the knock-in experiments, 200 ng of Cas9+sgRNA vector (designed with px330 for SEC61B 
and CLTA, and px459 for RIα) and 400 ng of an oligonucleotide donor DNA were transfected to 
HEK293FT cells per 24-well plate (Eppendorf). For CLTA and SEC61B, transient transfection 
of GFP1-10 and FACS enrichment for GFP+ cells were performed, followed by a negative sort 
two weeks later to select against stable incorporation of GFP1-10. For RIα, single-cell deposition 
of transfected cells with Cas9+sgRNA into 96-well plates was performed. Genomic DNA was 
extracted from cells and sequenced to confirm knock-in. 
Time-lapse fluorescence imaging 
Cells were washed twice with Hank’s balanced salt solution (HBSS, Gibco) and subsequently 
imaged in HBSS in the dark at 37°C. Forskolin (Fsk; Calbiochem), 3-isobutyl-1-methylxanthine 
(IBMX; Sigma), epidermal growth factor (EGF; Sigma-Aldrich), and histamine (Sigma-Aldrich) 
were added as indicated. Images were acquired on a Zeiss AxioObserver Z1 microscope (Carl 
Zeiss) equipped with a 40x/1.3 NA objective and a Photometrics Evolve 512 EMCCD 
(Photometrics, Tucson, AZ) controlled by METAFLUOR 7.7 software (Molecular Devices). 
GFP imaging was performed using a 480DF30 excitation filter and 505DRLP dichroic mirror 
and a 535DF45 emission filter; GFP-RFP FRET imaging was performed using a 480DF30 
excitation filter and 600DRLP dichroic mirror and a 653DF95 emission filter; RFP intensity was 
imaged using a 568DF55 excitation filter, a 600DRLP dichroic mirror, and a 653DF95 emission 
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filter; and YFP intensity was imaged using a 495DF40 excitation filter, a 515DRLP dichroic 
mirror, and a 535DF25 emission filter. All filter sets were alternated by a Lambda 10–2 filter-
changer (Sutter Instruments). Exposure times ranged between 50 and 500 ms and images were 
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Dissecting the dynamic interplay within biochemical networks requires the simultaneous 
monitoring of many signaling activities. Although optically-based, genetically-encoded 
biosensors have proven indispensable for uncovering spatiotemporal regulation within specific 
signaling pathways, combining multiple sensors in a single experiment has been difficult due to 
limited spectral space. To help bridge this gap, we developed two new classes of biosensors 
suitable for multiplexed imaging. The modular architecture and single-color properties of these 
new sensors expands the toolset for interrogation of several signaling pathways in a single cell. 
In order to further broaden the utility of these sensors, we designed additional kinase sensors and 
color variants. We also constructed and applied higher-throughput screening platforms for 
optimizing these sensors and improve their sensitivity. The multiplexed biosensors and screening 
methodologies presented here will help researchers unravel the complex regulation within 
signaling networks and advance the engineering of specialized sensors. 
Introduction 
Cells utilize a multitude of signaling pathways in order to encode, transduce, and process 
information. These pathways are marked by complex interactions between specialized enzymes, 
such as kinases and phosphatases, in order to enable specialized functions. Genetically-encoded 
biosensors, such as the ones mentioned in previous chapters, have proven instrumental in 
dissecting the spatiotemporal organization of certain signaling cascades by transforming specific 
biochemical activities into changes in fluorescence, at a single-cell resolution. However, these 
interactions rarely operate independently from one other and it is the crosstalk between different 
pathways that create essential emergent phenomenon and complex behavior. In order to probe 
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these intricate signaling networks, multiplexed biosensor measurements in which multiple 
signaling activities are monitored in parallel and in an individual cell become necessary. 
The primary challenges for multiplexing FP-based, genetically-encoded biosensors include the 
limited spectral space available for imaging multiple sensors and dampened signals in 
multiplexing experiments, which could be overcome by the design and optimization of novel 
sensors (Mehta et al. 2011). To this end, much work has focused on development and 
optimization of single-color and single-FP sensors in order to minimize each sensor’s spectral 
footprint (Mehta et al. 2018, Ross et al. 2018, Piatkevich et al. 2018). Here we highlight our 
recent contributions, which consist of two new classes of biosensors for multiplexed imaging and 
the development of a few screening techniques. This chapter is divided into two parts: Part 1 will 
introduce FLAREs (FLuorescence Anisotropy REporters) for ratiometric, single-color 
biosensing, and Part 2 will focus on screening efforts directed towards optimizing single-FP-










Part 1 – FLAREs: Single-color, ratiometric biosensors for detecting 
signaling activities in live cells 
 
Introduction 
Most FP-based, genetically-encoded biosensors fall into two categories: single-color or 
ratiometric. Single-color probes, such as the widely-used Ca
2+
-sensitive CaMP reporters utilize a 
single FP with a single pair of excitation and emission wavelengths, and thus leave more spectral 
space available for additional sensors (Akerboom et al. 2013). However, this single emission-
based readout can introduce unwanted measurement variation due to probe expression levels or 
imaging conditions. Ratiometric sensors, such as the FRET-based reporters mentioned earlier, 
can cancel these variations out at the expense of a larger spectral footprint (FRET channel 
divided by donor channel). Ideally, a class of sensors that could combine the robustness of 
ratiometric reporters with the smaller spectral occupancy of single-color probes could prove 
invaluable for multiplexed biosensing. 
In order to design a requisite sensor, we turned to the under-utilized phenomenon of homoFRET, 
where the polarization of emitted fluorescence depends on FRET between two identical 
fluorophores (Lakowicz et al. 2006). To prototype a homoFRET-based sensor, we took our 
optimized heteroFRET-based PKA activity sensor, AKAR4 (Depry et al. 2011), and replaced the 
donor and acceptor FPs with FPs of a single color (Figure 4.1a). We tested the different color 
variants in HEK293T cells, under fsk/IBMX stimulation conditions, by exciting with polarized 
light and measuring the loss of anisotropy of the emitted fluorescence. We found that several FP 
combinations reported a PKA-dependent, robust decrease in anisotropy (Figure 4.1a-c). The use 
of a single excitation/emission wavelength validates the homoFRET-based sensor as single-color 
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while the anisotropy parameter is inherently ratiometric, and thus we termed this type of sensor a 
FLARE (FLuorescence Anisotropy REporter). In this section, we describe extensions of the 
FLARE toolset to include reporters of other kinase activities and second messengers, and 


































Figure 4.1 Design and characterization of FLARE AKAR. (A) Schematic of a kinase activity FLARE (B) 
Diagram illustrating domain structure of FLARE-AKAR (top). Time-course of mean fluorescence anisotropy of 
Venus-cp172Venus FLARE-AKAR wild type (blue, N = 44) and kinase insensitive T-to-A mutant (red, N = 38) 
expressed in HEK293T cell, stimulated with 50 μM forskolin and 100 μM IBMX at t = 0 min, and 20 μM H-89 at 
t = 24 min (left). Dashed lines above and below represent standard error of the mean. Changes in anisotropy upon 
Fsk/IBMX stimulation for both FLARE-AKAR WT and T-to-A mutant (upper right, two-tailed t-test, p<0.0001), 
calculated as the difference between the mean anisotropy from t = 5 min to t = 7.5 min and the mean anisotropy of 
the baseline before drug addition. The mean for each is shown, with the error reflecting the standard error of the 
mean. Representative anisotropy pseudocolor image before Fsk/IBMX stimulation (t = 0 min), after Fsk/IBMX 
stimulation (t = 7.5 min), and after inhibition of PKA with H-89 (t = 24 min) (lower right) (C) Comparison of the 
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magnitude of the anisotropy change for different color variants of FLARE-AKAR upon stimulation with Fsk/IBMX 
including Venus-cp172Venus AKAR (N = 44), Venus-Venus FLARE AKAR (N = 32), EGFP-EGFP FLARE 
AKAR (N = 13), mCh-mCh FLARE AKAR (N = 22), mCerulean3 FLARE-AKAR (N = 10), and mCerulean3-




Results and Discussion 
A FLARE panel for kinases and second messengers 
The molecular architecture of the FLARE AKAR prototype differs minimally from other 
heteroFRET-based reporters, some of which were covered earlier. To expand the toolset to 
include sensors for other important kinases, we took the top-performing FP pair from the FLARE 
AKAR prototypes, mVenus–cpVenus (circularly permuted at position 172), and swapped out the 
PKA conformational switch for switches used in other kinase sensors. First, we sought to design 
a FLARE for PKC activity, so we replaced the PKA substrate domain in FLARE AKAR with the 
PKC-specific substrate domain from CKAR (C Kinase Activity Reporter) (Figure 4.2) (Violin et 
al. 2003). We transfected HEK293T cells and upon stimulation with phorbol 12-myristate 13-
acetate (PMA, 100ng/mL) to stimulate PKC activity, we observed a robust anisotropy decrease (-
0.02 ± 0.001, n=26) (Figure 4.2a). Next, we wished to create a FLARE version of EKAR-EV, 
the genetically-encoded biosensor for Erk activity. We exchanged the conformational switch for 
the Erk substrate peptide, a flexible EV linker, and a WW domain (PAABD), and tested the 
sensor in HEK293T. Treatment with EGF (100ng/mL) triggered an anisotropy decrease (-0.02 ± 
0.001) which could be reversed with the Erk inhibitor U0126 (20uM) (n=13) (Figure 4.2b). As 
negative controls, the phosphorylation mutants were also checked and failed to elicit stimulated 
104 
 
responses. To further expand the toolset for multiplexed imaging, we also wanted to make 
different color variants of these kinase sensors, and so we swapped out the mVenus-cpVenus 
pair for other pairs of same-color FPs, including mCherry-mCherry for red sensors and 
mCerulean3-mCerulean3 for cyan sensors. Testing these sensors with appropriate stimulation 
conditions yielded many successful color variants with signal-to-noise ratios summarized in 




























Figure 4.2 A panel of kinase activity biosensors (A) Domain structure of FLARE-CKAR (above). Time-course of 
fluorescence anisotropy of Venus-cp172Venus FLARE-CKAR WT (blue, N = 26) and kinase-insensitive mutant 
(red, N = 119) with addition of 100 ng/mL phorbol 12-myristate 13-acetate (PMA) at t = 0 min. Summary of 
response magnitudes (upper right, two-tailed t-test, p<0.0001), calculated as the difference between the mean 
anisotropy from t = 10 to t = 11.33 min and the mean anisotropy of the baseline before drug addition. The mean is 
shown, with the error reflecting the standard error of the mean. Representative anisotropy pseudocolor image before 
PMA addition (t = 0 min) and after PMA addition (t = 15 min). (B) Domain structure of FLARE-EKAR-EV 
(above). Time-course of mean fluorescence anisotropy of Venus-cp172Venus FLARE-EKAR-EV WT (blue, 
N = 13) and kinase-insensitive mutant (red, N = 16) expressed in HEK293T cell, with addition of 100 ng/mL EGF at 
t = 0 min and 20 μM U0126 at t = 25 min (left). Summary of anisotropy changes (upper right, two-tailed t-test, 
p<0.0001), calculated as the difference between the mean anisotropy from t = 10 min to t = 15 min and the mean 
anisotropy of the baseline before drug addition. The mean is shown, with the error reflecting the standard error of 
the mean. Representative anisotropy pseudocolor image before EGF stimulation (t = 0 min), after EGF stimulation 





Table 4.1 SNRs of several color variants of FLARE AKAR, FLARE CKAR, and FLARE EKAR-EV sensors 
 
 
Similarly to the FluoSTEPS, we wished to grow the FLARE panel to include sensors for second 
messengers. In order to make a Ca
2+
 version, we sandwiched the conformational switch from the 
Cameleon family of probes (Nagai et al. 2004), composed of calmodulin (CaM) and the 
Ca
2+
/CaM-binding peptide M13, between mVenus and cpVenus (Figure 4.3a). Transfecting the 
FLARE Cameleon into HEK293T and stimulating with ionomycin (1uM) and Ca
2+ 
(5mM) 
elicited a robust change in anisotropy (-0.03 ± 0.002, n=10) (Figure 4.3b). For a cAMP sensor, 
we took the same cAMP binding domain/switch derived from Epac and from our ICUE probe 
(Violin et al. 2007) and inserted it between mVenus and cpVenus. Stimulating the sensor with 
fsk/IBMX produced a positive change in anisotropy, consistent with cAMP-induced FRET 
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decreases in the original ICUE (+0.02 ± 0.001, n=40) (Figure 4.3c). The modular design of 
FLAREs establishes an easily-implementable strategy for generalizing the toolset to make 


































Figure 4.3 Design and characterization of FLARE second messenger sensors (A) Schematic of FLARE ICUE 
cAMP biosensor. (B) Domain structure of FLARE-Cameleon (top). Time-course of mean fluorescence anisotropy of 
Venus-cp172Venus FLARE-Cameleon (N = 10) with addition of 1 μM ionomycin and 5 mM CaCl2. Summary of 
anisotropy changes after 1 μM ionomycin and 5 mM CaCl2 (upper right) calculated as the difference between the 
mean anisotropy from t = 5 min to t = 7.5 min and the anisotropy of the baseline before drug addition Representative 
anisotropy pseudocolor image before and after 1 μM ionomycin and 5 mM CaCl2 addition. (C) Domain structure of 
the cAMP biosensor FLARE-ICUE (top). Time-course of mean fluorescence anisotropy of Venus-cp172Venus 
FLARE-ICUE (N = 40) with addition of 50 μM forskolin and 100 μM IBMX at t = 0 (left). Summary of anisotropy 
changes after 50 μM forskolin and 100 μM IBMX with respect to baseline (upper right), calculated as the difference 
between the mean anisotropy from t = 5 min to t = 7.5 min and the anisotropy of the baseline before drug addition. 
Representative anisotropy pseudocolor image before (t = 0 min) and after (t = 7.5) stimulation with Fsk/IBMX 
(lower right). Dashed lines above and below time course reflect standard error of the mean. 
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Multiplexed imaging of FLAREs in single cells  
In order to demonstrate the utility of FLAREs, we chose to deploy multiple sensors at once for 
parallel monitoring of signaling pathways. Two-channel imaging is routinely done, but 
simultaneous imaging of three signaling events is much less common due to sensor limitations.  
First, we expressed red FLARE AKAR, yellow FLARE EKAR, and cyan FLARE Cameleon into 
HEK293T cells. Sequential addition of fsk/IBMX, EGF, and thapsigargin (1uM) at three 
different times within a time course to stimulate PKA, Erk, and Ca
2+
, respectively, elicited 
appropriate responses in the FLAREs (n=17) (Figure 4.4a). Minimum crosstalk was observed 
between the three signals, highlighting the specificity and power of FLAREs for multiplexed 
interrogation. 
To test the sensors under more physiological, submaximal stimulation conditions, we turned to 
signaling within the pancreatic beta cell. As previously mentioned, the complex interplay of Ca
2+
 
and cAMP characterize an oscillatory circuit responsible for regulation of normal beta cell 
function (Ni et al. 2011). We wished to monitor these two signals in parallel, and so we 
transfected MIN6 beta cells with untargeted yellow FLARE ICUE and cyan FLARE Cameleon 
and stimulated with TEA. As expected, we observed Ca
2+
 and cAMP oscillating out-of-phase 
from one another (Figure 4.4b). Taken together, we envision the FLARE platform to serve as a 
powerful toolset for probing multiple signaling pathways through multiplexed imaging. Further 
development will include designing new FLAREs for other enzymes and second messengers, as 







Figure 4.4 Multiparameter imaging with FLAREs (A) Time-course of a representative HEK293T cell co-
expressing mCherry-mCherry FLARE-AKAR, mVenus-cp172Venus FLARE-EKAR-EV, and mCerulean3-
mCerulean3 FLARE-Cameleon, with 50 μM forskolin and 100 μM IBMX added at t = 0 min, 100 ng/mL EGF at 
t = 7.5 min, and 1 μM thapsigargin added at t = 32.5 min (N = 17). (B) Anisotropy response of a representative 
MIN6 cell co-expressing Cerulean3-Cerulean3 FLARE-Cameleon and Venus-cp172Venus FLARE-ICUE, showing 
















Single-FP biosensors, based on a single circularly-permuted fluorescent protein (cpFP), provide 
an alternative strategy for achieving multiplexed signaling interrogation. Recently, we designed 
and characterized a suite of single-FP sensors for monitoring PKA activity (Mehta et al. 2018) by 
sandwiching cpFP color variants (eg. cpGFP and cpBFP) between the PKA-specific substrate 
domain and the phosphoamino acid binding domain (PAABD) from the FRET-based PKA 
reporter AKAR4 (Depry et al. 2011). PKA-dependent phosphorylation of the substrate domain 
triggers a binding event with the PAABD, FHA1, which in turn modulates the protonation state 
of the cpFP’s chromophore and thus the photophysical properties. This modular design allowed 
us to successfully generalize this color suite to include sensors for other important kinases (eg. 
PKC and Akt) by swapping out the substrate domain and the PAABD. By utilizing these 
reporters, including organelle-targeted versions, we successfully demonstrated simultaneous 
multiplexing of six sensors in single cells. 
Despite the proven application of these first generation sensors, limitations include a relatively 
low signal-to-noise ratio compared to the Ca
2+
 biosensors and a color palette that can be further 
expanded. Here we introduce three single-FP biosensor screening methodologies and work to 
apply them for optimizing our first-generation of sensors. Although we demonstrate the 
screening function for PKA activity sensors in particular, similar approaches could be used for 






Figure 4.5 Design of ExRai-AKAR (A) Modulation of cpFP fluorescence by a phosphorylation-dependent 
molecular switch. ExRai-AKAR domain structure. (B) Representative ExRai-AKAR fluorescence spectra collected 
at (i) 530 nm emission and (ii) 380 nm or (iii) 488 nm excitation without (gray) or with (green) ATP in the presence 
of PKA catalytic subunit. n=3 independent experiments. 
 
 
Results and Discussion 
Improving the dynamic range for ExRai-AKAR and blueAKAR probes using a lysate 
screening approach 
 
In one of the first generation single-FP sensors for PKA, ExRai-AKAR (Excitation Ratiometric 
Activity Reporter – A Kinase Activity Reporter), cpGFP was used as the reporting unit. The 
design for ExRai-AKAR closely resembles the popular calcium reporter GCaMP where a Ca
2+
-
induced conformational change modulates the emission intensity of the cpGFP from a single-
peak excitation by altering the immediate electronic environment at the circularly-permuted site 
and chromophore (Chen et al. 2013). Interestingly, ExRai-AKAR displays two excitation peaks 
(ex: ~400nm and 509nm, em: 515nm) instead of the single excitation peak in GCaMP (509nm) 
and is reminiscent of the double-peaked wild-type GFP from A. victoria, despite having the 
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mutations designed to simplify the excitation spectrum (Figure 4.5) (Tsien 1998; Cormack et al. 
1996). Furthermore, phosphorylation by addition of purified catalytic subunit of PKA to purified 
sensor in the presence of ATP leads to a decrease in the 400nm excitation peak (approx. -50%) 
but an increase in the 509nm peak (approx. +100%). This unique behavior allows the ExRai-
AKAR probe to function as a ratiometric sensor where the ratio between the emitted 515nm 
fluorescence intensity excited at 509nm and 400nm cancels out the probe’s concentration-
dependence and imaging condition variations. Despite the large dynamic range (DR) of ExRai-
AKAR post fsk/IBMX stimulation (approx. 2-fold increase in excitation ratio), especially 
compared to the DR of previous FRET-based PKA reporters (Depry et al. 2011), some low-
amplitude PKA signaling events, such as compartmentalized signals, might still evade detection. 
Thus, we sought to further improve the DR of the ExRai-AKAR sensor. 
Crystal structures and previous work on the optimization of GCaMP and other cpGFP-based 
sensors suggested that the residues in the vicinity of the phenolate in the fluorophore were 
critical for the sensor properties (Tian et al. 2010). This included parts of the seventh beta strand 
in the FP, the site of circular permutation, and the linkers between the cpFP and the sensor-
specific domains. For ExRai-AKAR, we decided to focus on optimizing the sensor by modifying 
the linkers between the PKA substrate domain and the cpGFP, and the cpGFP and FHA1. 
Unfortunately, lack of crystal structures of the sensor in the high- and low-PKA activity states 
precluded using a semi-rational design approach where replacing specific amino acids with 
specific residues within the linkers is followed by a small-scale screen. Instead, we designed an 
ExRai-AKAR sensor library where two randomized amino acids were inserted into each of the 





 = 160,000 variants) required a larger-scale/higher-throughput screening method for 
identifying sensor variants with an improved DR. 
The screen we adopted consisted of three parts: 1) identification of promising sensor variants 
from E.coli colonies expressing the sensor on agar plates, 2) testing of selected variants using 
crude lysates and purified PKA catalytic subunit (PKAcat), and 3) a follow-up validation in 
mammalian HEK293T cells (Figure 4.6). In the first part, we transformed and expressed the 
ExRai-AKAR linker library in BL-21 E.coli and measured the emitted green fluorescence from 
each bacterial colony during excitation at 390nm and 488nm using a home-built setup. The 
colonies displayed a wide variation in fluorescence under both excitation wavelengths. In order 
to maximize the change in the excitation ratio, we reasoned that colonies that displayed high 
intensity fluorescence under 380nm excitation but low intensity under 488nm could yield 
optimized ExRai probes due to the presence of the sensors in a low-PKA state in the bacteria. To 
test, we selected 480 such colonies and inoculated them in several 96-well plates for growth, 
induction, and finally lysis. For assessing the PKA sensitivity of the selected library variants, we 
measured the excitation ratio of the crude, clarified lysates containing in the presence and 
absence of purified PKAcat. We identified 20 potentially improved sensors (>4-fold increase in 
the emission ratio ΔR/R upon PKAcat addition) and subcloned them into mammalian expression 
vectors for follow-up testing in HeLa cells. From this work, we identified a second-generation 
ExRai-AKAR (ExRai-AKAR2) sensor with phenylalanine-cysteine (FC) in the first linker 
position and leucine-leucine (LL) in the second linker position. Upon fsk/IBMX stimulation, this 
optimized sensor displayed almost an approx. 9.5-fold increase in the excitation ratio (-80% 
decrease under 380nm excitation, 2-fold increase under 488nm excitation), improving the DR 




sensor, for example its pH sensitivity and subcellular targeting effects, should be performed for 
validation. Additional optimization focusing on the phosphorylated substrate’s interaction with 
















Figure 4.7 ExRai-AKAR2 optimized sensor (A) 
Schematic showing the ExRAI-AKAR2 sensor with the 
optimized FC/LL linkers. Fsk/IBMX treatment in HeLa 
cells elicit an approx. 9.5-fold change in the excitation 
ratio (green trace). ExRai-AKAR1 (teal) and AKAR4 
(blue) are shown for comparison. 
116 
 
In parallel with ExRai-AKAR, we wished to improve the DR of the previously published 
blueAKAR probe (Mehta et al. 2018) for use in multiplexed imaging. Unlike the ExRai-AKAR 
sensor, blueAKAR is a negative probe and has only a single excitation peak; however, the 
cpBFP reporting moiety from blueAKAR shares sequence similarity with cpGFP, and so we 
hypothesized that a similar linker library design and screen could work here. Once again, we 
replaced amino acids in the two linker regions of blueAKAR with randomized amino acids 
(Linker1/Linker2: AI/SM  XX/XX) and expressed the library variants in E.coli colonies. 
Fluorescence overall from the colonies was weak (ex: 390nm, em: 440nm), but we still selected 
96 of the brightest colonies, reasoning that these variants represented the low PKA state and 
might yield a larger decrease upon PKA phosphorylation. By screening the crude lysates, 
followed by testing potential hits in HEK293T, we identified a two linker variants (AI/HM, 
AI/HL) with a decrease -17.8% ± 0.4% and -19% ± 2.5% (n=5, 3) upon fsk/IBMX, representing 
an improvement of approx. 2-fold over the first-generation blueAKAR (Figure 4.8a). In parallel, 
we also decided to substitute blueAKAR’s linkers with other winning linker variants from the 
screen for an improved ExRai-AKAR with the idea that the large PKA-dependent decrease in the 
400nm excitation peak of ExRai-AKAR might function similarly to the decrease of the single 
excitation peak in blueAKAR. Surprisingly, we found a blueAKAR variant with LQ/LL for 
linkers displayed comparable fluorescence intensity and a -49.3% ± 2.9% response to fsk/IBMX, 
an approx. 5-fold improvement over the first-generation blueAKAR. This hints at not only a 
possible common mechanism for these single-FP sensors, but also potential drawbacks to our 
screening methodology. We might have missed the LQ/LL linker variant in our initial lysate 
screen for a few possible reasons, including a low-complexity library prep (inadequate coverage 




at any screening/selection stage. For example, our selection criteria for sensors from the bacterial 
colonies might have been ill-guided, or our limited number of colonies for lysate screening 
prevented us from sampling a representative collection of linker variants. In any case, a platform 
that could improve the throughput of testing sensor variants would be valuable in combating this 
potential lysate screening “bottleneck” and provide a faster path with higher capacity for 







Figure 4.8 Optimized blueAKARs (A) Linker variants identified from the lysate & mammalian cell screen. Dark 
blue is the AI/SM original published linker for comparison. Medium blue is AI/HM linker variant. Light blue is 
AI/HL linker variant. Normalized blue fluorescence intensity was measured. Fsk/IBMX triggered decreasing 
responses (-9.6% ± 0.6%, -17.8% ± 0.4%, -19% ± 2.5%; n=5, 3, 6). (B) blueAKAR(LQ/LL) linker variant 
demonstrated a superior response to fsk/IBMX (-49.3% ± 2.9%, n=5) and was reversed with H89. 
 
 
Optimizing a greenAKAR probe for single-color applications with a bacterial colony-based 
screen   
Although the ratiometric readout is adventitious for quantification and canceling out probe-
dependent effects, the ExRai sensors still suffer from limitations in multiplexing due to the need 
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to excite at two wavelengths. Therefore, we next sought to design a “true” greenAKAR, a PKA 
sensor that still responded to PKA activity under 488nm excitation, but had minimum 
fluorescence under 380nm excitation. Initially, we utilized the same linker library from the 
previous ExRai-AKAR screen because of the observed variation in green fluorescence under 
both excitations. We hypothesized bacterial colonies expressing successful greenAKAR sensors 
would either be dim in both channels, or dim under 380nm excitation and bright under 488nm 
excitation, representative of the low-PKA state. However, subsequent lysate screening of 
selected colonies under both criteria failed to produce a greenAKAR sensor (data not shown). 
This can most likely be explained by the absence or low expression of fluorescent sensors in the 
dim/dim case, something the previous ExRai-AKAR screen didn’t suffer from due to “self-
normalization” from the bright 380nm excitation signal. The second selection criterion 
(dim/bright) was most likely inappropriate for finding a greenAKAR and also suffered from a 
lack of a good benchmark for the bright 488nm state. 
In order to continue working with the ExRai-AKAR linker library for designing a greenAKAR, 
we decided to abandon the colony selection step for lysate screening and instead develop an 
alternative screening platform that tested PKA responsiveness of library variants in situ, within 
the bacterial colony on the agar plate. We figured that this strategy could eliminate the lysate 
screening “bottleneck,” reduce the involved labor, and increase the overall throughput of a 
library screen. Our approach, inspired by a similar approach (Ibraheem et al. 2011), consisted of 
the design of a bacterial dual expression vector where one constitutive promoter drives 
expression of the biosensor library and an inducible promoter controls expression of a signaling 
enzyme. Imaging of the sensor library in colonies, first in the absence and then in the presence of 
the inducer, could theoretically allow researchers to capture the fluorescence of each variant’s 
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low and high signaling states while still on agar plates. To first test this strategy, we created a 
dual expression vector comprised of ExRai-AKAR2 under the control of a constitutively active 
T7 promoter. The gene for PKAcat, tagged with an mScarlet RFP, was inserted after an 
arabinose-inducible promoter and determined not to need additional factors due to the abundance 
of ATP present in E.coli (data not shown). Spraying transformed E.coli colonies with arabinose 
induced robust expression of PKAcat (approx. 6-fold change, from observed RFP intensity) over 
the span of several hours, which subsequently induced an excitation ratio change (approx. +60% 
fold, 488nm/390nm) in the colonies (Figure 4.9a,b). Aside from slight optimization of the agar 
plates (addition of glucose to inhibit leaky expression from the arabinose-inducible promoter), 





























Figure 4.9 ExRai-AKAR2 in situ colony response to induced PKAcat expression. (A) Fluorescence images of 
bacterial colonies on petri plate with LB-agar. Spraying arabinose induces strong expression of mScarlet-tagged 
PKAcat after 4 hours, shown above. In a separate experiment/dish, we sprayed the bottom right half the plate and 
created a spatial gradient of arabinose. Constitutively-expressed ExRai-AKAR2 responds in the 488nm/380nm ex 
ratio shown below according to the spatial gradient. (B) The response of the ExRai-AKAR2 is approx. +60% in 
colonies. As a negative control, the phosphorylation mutant does not respond.  
 
We then decided to apply this platform to screen for greenAKAR. We used the same linker 
library (XX/XX) from the previous ExRai-AKAR screen, but tagged the C-terminus of the 
sensor with a long, rigid linker ([EAAAK]5 to prevent FRET) followed by mScarlet for 
normalization of sensor concentration (Figure 4.10a) (Chen et al. 2014). Once again, untagged 
PKAcat was placed under control of the arabinose-inducible promoter. For a small-scale 
demonstration of the technique, a total of 25 agar plates were screened and the three relevant 
fluorescence channels were monitored over the course of about six hours post arabinose 
induction. After applying analysis filters for the colonies, such as PKA-induced response in the 
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488nm excitation channel, normalized brightness in the 488nm excitation channel, and 
normalized brightness in the 390nm excitation channel, a select few linker variants were chosen 
for subcloning and testing in HEK293T cells. From these hits, one linker variant (FK/LS) was 
identified and briefly characterized (Figure 4.10b). In HEK293T cells, this variant showed a dim 
400nm excitation fluorescence but still maintained a robust PKA-induced response under 488nm 
excitation (excitation increased approx.. 2-fold increase; GFP intensity increased +70.3% ± 4.4% 
in HEK293T, n=17) (Figure 4.10c). This greenAKAR candidate provides an excellent starting 
point for subsequent screens in order to increase the DR and further reduce the brightness of the 
390nm state. Crystal structures could help guide a successful mutagenesis strategy, possibly by 
identifying the distributed UV-triggered excited state proton transfer (ESPT) network, the likely 
mechanism behind the 390nm excitation (Jung et al. 2005). However, some involved residues 
might also function in the maturation of the fluorophore, and so an untargeted mutagenesis 
approach in parallel might be appropriate. The colony-based screening methodology presented 
here increased the throughput at which we could functionally test sensor libraries and represents 























Figure 4.10 Screen for a greenAKAR. (A) Schematic of the dual expression screening vector. Arabinose-inducible 
promoter (within “AraC to pBAD” insert) drives the expression of PKAcat. T7 promoter drives expression of a 
sensor library where randomized amino acids (XX/XX) are inserted at the linker sites between PKAsub and cpGFP, 
and cpGFP and FHA1. The greenAKAR library variants are tagged with mScarlet for normalization. (B) Excitation 
spectra characterization of a greenAKAR library variant found (linker: FK/LS) with reduced 380nm excitation 
(compare with ExRai-AKAR in Figure 4.5b). PKAcat addition triggers approx. 2-fold increase in the 488nm 
excitation peak (with E.coli lysate with expressed greenAKAR). (C) greenAKAR library variant (linker: FK/LS) 




Assessing the use of FACS for high-throughput screening of single-color biosensor libraries 
in mammalian cells 
 
Even with the increased throughput achieved by assessing PKA responsiveness in bacterial 
colonies, we were still unable to approach complete sampling of the entire ExRai-AKAR linker 
library. We also noted that many of the top hits from the ExRai-AKAR lysate screen failed to 
elicit a marked improvement when tested in mammalian HEK293T, possibly highlighting a 
sensor’s dependence on redox environment or the presence/absence of extraneous factors. For 
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these reasons, we sought to raise the throughput of our single-FP sensor screen once again and 
shift our testing to only mammalian cells. 
Fluorescence Activated Cell Sorting (FACS) allows for the rapid, sensitive interrogation and 
selection of individual cells based on fluorescence intensity. With an assessment rate of 
thousands of mammalian cells per second, the potential increased throughput inspired us to test 
the technique’s ability to enrich/select for desired biosensor variants. To begin, we transfected 
ExRai-AKAR2 into HEK293T and passed the cells through the sorter, measuring green emission 
(530nm or 520nm) under 488nm and 405nm excitation. The fluorescent cells were highly 
correlated in both channels because of the ratiometric nature of the ExRai-AKAR2 sensor 
(Figure 4.11a). Variation along the regression line is primarily attributable to differences in the 
cell-to-cell expression of the sensor, while orthogonal variation is due in part to differences in the 
low, basal PKA activity state. Treating the entire population of cells with fsk/IBMX triggered a 
shift of the correlated population, indicating a sensor response (Figure 4.11b). To order to better 
evaluate the FACS procedure, we then collected a subsample of cells from within a range in both 
channels and stimulated PKA activity with fsk/IBMX addition. Re-sorting this subsample 
produced a large shift in approximately 80% of the population (approx. 2.5-fold in the 405nm ex 
channel and 5-fold in the 488nm channel), indicating a robust, high-SNR PKA response (Figure 
4.11c,d). The other 20% of the re-sorted cells failed to respond to the fsk/IBMX treatment, likely 
because they died after the first sort. As a “purity” check and a PKA specificity check, we ran re-
sorts on an unstimulated subsample and a subsample of ExRai-AKAR2 (T/A) phosphorylation 
mutant cells (data not shown), respectively, and observed no shift or response (Figure 4.11c). 
Satisfyingly, the relative spread in the ExRai-AKAR2 shifted population resembled the spread of 







from noise. In order to demonstrate the ability to decouple the brightness in each channel from 
the sensor expression variability, we inserted mScarlet with a self-cleaving P2A peptide (Liu et 
al. 2017) behind the ExRai-AKAR2 for normalization and successfully repeated the experiments 
(data not shown). By collecting cells from a shifted population, the transfected plasmid DNA 
was recovered and could be used in additional rounds of mutagenesis for a directed evolution 












Figure 4.11 FACS on ExRai-AKAR2. (A) FACS profile on HEK293T cells transfected with ExRai-AKAR2. (y-
axis: 405nm ex/520nm em; x-axis: 488nm ex/530nm em) (B) FACS profile on cells from A treated with fsk/IBMX. 
The shift of the entire population indicates a robust response of the ExRai-AKAR2 sensor. (C) Subpopulation of 
cells taken from A (gated inside orange box) and re-sorted as a “purity check.” (D) Subpopulation of cells from C 
were treated with fsk/IBMX, approx. 80% of the cells responded robustly as seen in the subpopulation shift. 
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Prominent hurdles with the practical implementation of a FACS-based screening approach 
include 1) using the sorter to identify a single library variant at a time, and 2) assessing PKA 
activity responsiveness of the variant relative to other variants. Multiple plasmids can enter and 
express under transient transfection (sometimes up to 50,000 for current transfection protocols, 
Cohen et al. 2010); for a sensor library, this means that the response in each cell will be the 
expression-weighted average of all sensors present. In order to tackle this limitation, we decided 
to explore the use of a sparse transfection as a low-cost, easily implementable strategy. We 
reasoned that a mammalian expression plasmid library could be effectively diluted by including 
a bacterial expression plasmid (Piatkevich et al. 2018). Using cationic lipid-based transfection, 
this would allow delivery and expression of a small number of library variants per cell. To test 
this, we constructed a mock library with nuclear-targeted mCherry RFP and nuclear-targeted 
Venus YFP (1:1), and diluted it with a pRSETb bacterial expression vector (1:100). We 
transfected in HEK293T (containing large T antigen which can facilitate replication of 
mammalian expression vectors with an SV40 ori) but found the expression/brightness to be too 
low in most cells. In order to optimize, we transferred the cells to 33°C in order to slow the 
growth for 96hrs post transfection without impairing the protein expression. We then assessed 
the nuclear fluorescence and found approximately 65% of cells were nonfluorescent while about 
20% were either yellow or red, divided in a 1:1 ratio, meaning that those single-color cells 
received/expressed primarily one tagged FP over the other (Figure 4.12a,b). Potential follow-up 
could include an antibiotic selection to enrich for cells with library variants. The separation of 
the fluorescent population and relatively high transfection efficiency/expression demonstrates the 
utility of performing a sparse transfection for sensor screening. To address the second hurdle, an 
alternative strategy for enriching a library, if the SNR of the desired variants relative to the entire 
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library precludes selection, might encompass choosing and re-sorting several subsamples post 
stimulation within a range of normalized brightness. Additionally, if the cell-to-cell response 
variability muddles the ability to identify hits or a re-sort is impractical, fusing either a 
catalytically-active or inactive kinase to the sensor library might capture the sensor in either the 
high or low reporting states. Performing a single sort, collecting cells at normalized brightness 
extrema, and deep sequencing to find the overlapping sensor variants might embody a high-
throughput screening approach. FACS-based screening methods hold promise for expanding the 
biosensor toolset and catapulting current efforts in the lab, specifically including optimizing 
single-color red sensors as well as unique photoconvertible reporters of second messengers. 
 
 
Figure 4.12 Sparse transfection testing in HEK293T. (A) Images of HEK293T cells sparsely transfected with 
nuclear-targeted Venus and mCherry (scale 250um). (B) Quantification of yellow and red fluorescence intensity for 
each cell in A. Q1: single red cells, Q2: both red and yellow (both constructs expressed), Q3: non-fluorescent cells, 







Complex biochemical processes shape the intricate signaling networks essential for life. 
Genetically-encoded biosensors capable of multiplexed imaging allow simultaneous reporting of 
many of these “molecular conversations” within individual cells. This information is 
indispensable in helping unravel the complicated interplay between signaling pathways. Here we 
highlighted two new families of sensors with suitable multiplexing properties. FLAREs are 
single-color, ratiometric probes for monitoring enzymatic activity or second messenger 
concentration. The sensors rely on changes in homoFRET, and the modular design facilitates 
development of color variants and sensors for other targets. The ExRai sensors are single-FP, 
excitation-ratiometric probes that detect biochemical processes through modulation of the 
electronic environment of a genetically-encoded fluorophore. Designing and optimizing 
biosensors, especially the single-FP family of sensors, can be difficult and time-consuming due 
to an inability to accurately predict molecular states and sensor responses. Thus, we designed and 
described a few screening platforms to rapidly assess and select changes to the single-FP sensors. 
Using these methodologies, we optimized ExRai-AKAR, a blueAKAR, and finally a 
greenAKAR. These screening platforms will likely continue to help design and develop better 







Materials and Methods 
Gene Construction 
Color variants of the FLAREs were created by replacing the genes for the fluorescent proteins in 
other FLARE AKAR variants in pRSET-B, either between the BamHI and SphI sites for the N-
terminal fluorescent protein, or SacI and EcoRI for C-terminal fluorescent proteins. Finalized 
constructs intended for mammalian expression were then sub-cloned into a modified pcDNA3 
expression vector between the BamHI and EcoRI sites. FLARE variants of other sensors were 
created by amplifying the molecular switch from EKAR-EV, CKAR2, Cameleon and ICUE3 
with primers encoding the SphI and SacI sites, digesting the PCR product with SphI and SacI 
enzymes, and ligating them to the relevant pRSET-B FLARE AKAR plasmid digested with SphI 
and SacI to remove the domains involved in the molecular switch for FLARE AKAR. The final 
constructs were then subcloned into a modified pCDNA3 expression vector between the BamHI 
and EcoRI sites. Targeted versions of the sensors were created either by PCR amplifying the 
sensor with primers containing the targeting sequence and ligating it to the pCDNA3 expression 
vector between BamHI and EcoRI, or by subcloning the construct into a plasmid already 
containing the targeting sequence. N-terminal targeting sequences were placed between HindIII 
and EcoRI, and C-terminal targeting sequences between EcoRI and XbaI. All cloning steps were 
performed using DH5α strain of E. coli. 
The threonine to alanine mutants for Venus-cp172Venus FLARE AKAR and FLARE EKAR 
were created by performing site-directed mutagenesis using a standard single-primer PCR-based 
protocol. The threonine to alanine mutant for Venus-cp172Venus FLARE CKAR was created 
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using Gibson assembly, amplifying the appropriate fragment with a primer containing the 
desired mutation. 
For the ExRai-AKAR optimization, a randomized linker library was created by PCR amplifying 
cpGFP with flanking (NNS)3 at linker positions for and dropping the insert into a PCR-amplified 
pRSETb construct already containing the remainder of the biosensor (PKAsub/FHA1). The dual 
expression construct was created by PCR amplifying the arabinose operon from the pBAD 
vector and inserting it into the backbone of pRSETb containing ExRai-AKAR2 using Gibson 
Assembly. The genes for PKAcat (S. Taylor) and mScarlet were then inserted into the pBAD 
operon using Gibson Assembly. For the dual expression linker library, mScarlet was moved 
downstream of the ExRai sensor and fused via a rigid linker (EAAAK)5 to prevent FRET. The 
linker library for screening in the dual expression vector was constructed using PCR 
amplification, identical to above. For assessing sensor responses in HEK293T cells as well as for 
FACS, the selected linker variants and ExRai-AKAR2 were cloned into pcDNA3 mammalian 
expression vector (BamHI/EcoRI). 
Cell Culture and Transfection 
HEK293T cells were maintained using Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. Cells were 
seeded onto a 35-mm glass-bottom imaging dish and incubated at 37°C with 5% ambient carbon 
dioxide. HEK293T and MIN6 cell lines were maintained separately from other cells and were 
screened regularly to confirm the absence of mycoplasma contamination using Hoechst staining. 
As the origin of the cells was not central to the nature of these experiments, we did not further 
validate the identity of the cell lines. Cells were transfected using Lipofectamine 2000 
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(Invitrogen), Polyjet (SignaGen) and incubated for 12–48 hr before imaging. The growth media 
was removed immediately before imaging, and the cells were washed two or more times with 
Hanks Balanced Salt Solution (HBSS) buffer with glucose at room temperature. The cells were 
imaged in HBSS buffer with glucose at either room temperature or 37°C. 
Fluorescence Imaging 
Fluorescence Polarization Microscopy 
Widefield images were collected using a Zeiss AxioObserver equipped for fluorescence 
polarization microscopy, using one of two setups. In the first setup, a wire grid polarizer 
(Meadowlark Optics) was placed in the excitation pathway between the LED illuminators and 
reflector turret containing filter cubes specific for CFP (Zeiss), YFP (Zeiss), and mCherry 
(Semrock). Images were generally collected using a 20 × 0.75 NA objective lens. Polarizations 
parallel and perpendicular to the excitation polarizations were separated using Optical Insights 
Dual-View using their polarization splitting module. Both images were simultaneously collected 
in a single image collected by a water-cooled Orca-R2 (Hamamatsu). In the second setup, a 
polarizer (Chroma) was placed in the excitation pathway between the xenon arclamp and the 
excitation filters. Images were collected using a 20 × 0.45 NA objective lens. Polarizations were 
separated using an Opto-Split II LS image splitter, with two wire grid polarizers (Meadowlark) 
oriented parallel and perpendicular to the excitation polarizer. Images of both polarizations were 
collected using a Hamamatsu Flash 4.0 sCMOS camera. Two-photon imaging was performed 
using a Zeiss 7 MP with GaAsP non-descanned detectors housed at the University of Maryland 
School of Medicine confocal facility. Coherent Chameleon and OPO lasers were used for 
excitation. Fluorescence was filtered using an ET680 short pass filter for two-photon microscopy 
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(Chroma) prior to separating polarizations with a one inch broadband polarizing beamsplitter 
cube (Thorlabs) mounted using a custom 3D printed cube. Images were collected using a 10×, 
0.3 NA Plan-apochromat objective lens. In vivo imaging was performed on C57Bl/6 mice under 
isoflurane anesthesia. 
Epifluorescence Imaging 
Cells were washed twice with Hank’s balanced salt solution (HBSS, Gibco) and subsequently 
imaged in HBSS in the dark at 37°C. Images were acquired on a Zeiss AxioObserver Z1 
microscope (Carl Zeiss) equipped with a 40x/1.3 NA objective and a Photometrics Evolve 512 
EMCCD (Photometrics, Tucson, AZ) controlled by METAFLUOR 7.7 software (Molecular 
Devices). Dual GFP excitation ratio imaging was performed using a 480DF30 excitation filter 
and 505DRLP dichroic mirror, a 380DF10 excitation filter and 450DRLP dichroic mirror, and a 
535DF45 emission filter; BFP intensity was imaged using a 380DF10 excitation filter, a 
450DRLP dichroic mirror, and a 475DF40 emission filter; RFP intensity was imaged using a 
568DF55 excitation filter, a 600DRLP dichroic mirror, and a 653DF95 emission filter; YFP 
intensity was imaged using a 495DF40 excitation filter, a 515DRLP dichroic mirror, and a 
535DF25 emission filter. All filter sets were alternated by a Lambda 10–2 filter-changer (Sutter 









Image analysis was performed using Fiji (ImageJ) open-source image processing software. 
Polarization images were cropped and aligned using either the Zeiss Axiovision software or 
Fiji’s built-in StackReg registration plugin. In Fiji, regions of interest (ROIs) were drawn around 
each cell, as well as one in the background. ROI intensities were background subtracted in each 
channel to estimate fluorescence emission intensity, and anisotropy was calculated as described 
(Lakowicz 2006). Anisotropies were calculated using the conventional equation: 
r = (P−gS) / (P+2gS) 
where g is the correction factor that accounts for differences in polarization transmission 
efficiencies within the instrument. The g-factor was calculated using an isotropic fluorescein 
solution as described (Piston et al. 2008). Delta anisotropy was calculated by subtracting the 
anisotropy at each time point by the anisotropy at the time point right before drug addition. The 
magnitude of the anisotropy changes were calculated by taking the difference between the 
average anisotropy when the signal peaked or plateaued and the average anisotropy of the 
baseline time points before drug was added. 
Epifluorescence Imaging 
Raw fluorescence images were corrected by subtracting the background fluorescence intensity of 
a cell-free region from the emission intensities of biosensor-expressing cells. GFP excitation 
ratios (F480/F380) were then calculated at each time point. The resulting time-courses were 
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normalized by dividing the ratio or intensity at each time point by the basal value at time zero 
(e.g., F/F0 or R/R0), which was defined as the time point immediately preceding drug addition. 
Analysis was performed in MATLAB. Graphs were plotted using GraphPad Prism 5 (GraphPad 
Software). 
Linker Screening 
Linker libraries were transformed into BL21 E.coli and plated on LB agar plates supplemented 
with ampicillin and glucose (20mM). Fluorescence from the bacterial colonies were measured 
using a broad-spectrum lamp source (MAX-303, Asahi Spectra) with excitation filters and 
monitored by a Thorlabs USB digital camera mounted behind a Thorlabs emission filter wheel. 
The images were analyzed using ImageJ (v. 1.47g). For the lysate screen, pellets in 96 well 
plates were lysed (B-PER, ThermoFisher) and fluorescence was monitored with Tecan 
Spark20M plate-reader. Purified PKAcat (gift from S. Taylor) (21ug/ml) and ATP (100uM) was 
added to the lysates to assess biosensor response. For the dual expression platform, 1M arabinose 
was sprayed onto the plates and incubated at 37C. Excitation spectra of clarified lysate was 
measured on a fluorimeter (Horiba). For FACS, a BD Influx was used (Sanford Consortium 
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Conclusions and Future Perspectives 
Cellular signaling networks are spatiotemporally organized and feature a high degree of 
connectivity between many different biochemical pathways. Genetically encoded biosensors 
have been instrumental in helping researchers probe this organizational regulation. In this 
dissertation, we highlighted the utility of these reporters by employing them to study 
compartmentalized signaling as well as multiple signals within the same reference frame. Using 
a cAMP biosensor fused to a scaffold protein, we uncovered a novel mode of compartmentalized 
regulation within the Ca
2+
-cAMP-PKA oscillatory circuit in pancreatic beta cells. We then 
extended the fusion-based approach for studying signaling microdomains by developing a suite 
of FRET-based biosensors that are amenable for monitoring endogenous compartments. Finally, 
we unveiled a new set of sensors that are suitable for multiplexed interrogation of multiple 
signaling pathways within the same live cell.  
Within the biosensor field, future progress will most likely include the design and optimization 
of better, more robust reporters. For example, screening and development of sensors with 
enhanced sensitivity and that use longer wavelengths have allowed researchers to deploy these 
tools in vivo and observe single-cell activity within an organism (Piatkevich et al. 2018; Qian et 
al. 2019). Further progress will also include the development of more sensors that incorporate 
additional information into their output. For example, the innovative biosensor CaMPARI works 
as a coincidence detector and photoconverts from a green fluorescent state to a red fluorescent 
state only in the presence of both Ca
2+
 and UV light, and thus allows researchers to highlight 
active neural circuits during behavior (Fosque et al. 2015). Also, sensors that report biochemical 
activity in a format adaptable for super-resolution imaging has granted researchers a unique 
glimpse into a cell’s nanoscale signaling architecture (Mo et al. 2017). Expanding the repertoire 
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of these, and other sensors, and iteratively improving them will continue to advance our 
understanding of signaling networks.   
Despite the advantages fluorescent protein-based biosensors have for monitoring biological 
activity in single cells, some areas of application remain currently out of reach. For example, 
enhancing our understanding of the connection between the brain and behavior requires 
knowledge of neuronal wiring and recording the activity of intact neural circuits in real-time. 
Although advances in microscopy, improved genetically encoded voltage and Ca
2+
 biosensors, 
and revolutionary techniques in genetic manipulation have spearheaded progress in this arena in 
the last decade, we are still only able to optically excite and monitor an extremely small subset of 
neurons from a complex organism’s brain at a given time. Thus, future work focusing on 
“scaling-up” single-cell biosensors for an entire-brain/whole-organism recording might instead 
rely on a different informational medium than light, such as DNA or RNA (Farzadfard et al. 
2018; Sheth et al. 2018). 
Nevertheless, genetically encoded biosensors have revolutionized our knowledge of cell 
signaling and spatiotemporal organization by allowing researchers a privileged view of 
biochemical communication inside individual, living cells. The future of these biosensors and 
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